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Cellular plasma membrane is not just a barrier separating inner and outer cellular 
volumes but it is critical for communication with the extracellular milieu. Indeed, 
the plasma membrane enables the transfer of many compounds important for the cell 
metabolism and for chemical and electrical signaling. The capsaicin receptor 
(Transient Potential Vanilloid 1 or TRPV1) belongs to the fascinating class of 
polymodal membrane receptors that integrate several physical and molecular stimuli 
and translate them into intracellular signaling. More specifically, TRPV1 is a 
nonselective voltage-dependent, temperature-dependent, ligand-dependent cation 
channel with a preference for Ca2+. Modulators of TRPV1 activity include: noxious 
heat, low pH, capsaicin, and capsaicin analogues like resiniferatoxin (RTX). TRPV1 
is expressed both in sensory neurons, where it is involved in pain signaling, and in 
many other cell types (e.g. endothelial cells). The research on TRPV1 is driven by 
its important biological role, but it is also believed that TRPV1 activation 
mechanism could be relevant to the discovery and design of drugs capable of 
controlling TRPV1 activity and therefore pain stress in humans. Surprisingly, many 
molecular properties of TRPV1 are still largely unknown. 
Among the unclear aspects of TRPV1 activity, a hot topic is represented by its 
interactions with the cytoskeleton. TRPV1 was recently proposed to bind to 
microtubule β-tubulin. Activation of TRPV1 was demonstrated to yield fast 
disassembly of microtubules, albeit at agonist concentrations much above saturation. 
This suggests that TRPV1 may regulate some specific cell functions (and possibly 
neuronal functions) through cytoskeleton reshaping. Yet, the alleged direct binding 
of TRPV1 to microtubules raises the question: do microtubules also modulate 
TRPV1 activity? If so, the microtubule-TRPV1 interplay may play a role in tuning 
cell response to TRPV1 activation upon different factors including noxious stimuli. 
The activation of the TRPV1 due to noxious stimulation is followed by the 
attenuation of nociceptive sensory neuron excitability, making nociceptors partially 
or totally refractory to subsequent stimuli. Available knowledge is limited to acute, 
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Ca2+-dependent, desensitization. Conversely, long-term TRPV1 desensitization 
mechanisms are largely unknown. It was speculated that long-term desensitization 
could involve TRPV1 withdrawal from the cell surface. Indeed, similar to members 
of other receptor families, activity-dependent control of plasma membrane-resident 
receptors may involve TRPV1 endocytosis followed either by receptor recycling to 
the plasma membrane or by its degradation through the proteosomal or lysosomal 
pathways. A recent study showed that agonist stimulation promoted receptor 
internalization via a clathrin-independent endocytotic mechanism. The classical 
alternative to clathrin-dependent endocytosis of protein is represented by caveolar 
endocytosis, which is in turn is modulated by lipid rafts, membrane microdomains 
enriched in cholesterol and saturated lipids. Interestingly, several members of the 
TRP family were demonstrated to reside near caveolin-1, the main structural protein 
of caveolae. Thus, I may question whether caveolin-1 is implied in the clathrin-free 
endocytosis of TRPV1. If so, TRPV1 dynamics and interactions could be influenced 
by membrane raft regions. 
Answering these questions requires high-resolution / high-sensitivity imaging of 
the receptor to account for its specific dynamics and interaction interplay. In my 
thesis I set out to address these issues by a toolbox of fluorescence imaging 
techniques such as Förster Resonance Energy Transfer, Fluorescence Anisotropy 
Imaging, and Spatio-temporal image correlation spectroscopy. I investigated 
receptor properties such as membrane mobility, microtubule and caveolin-1 binding, 
and TRPV1 oligomerization status. My experimental strategies benefited from the 
use of genetically-encodable fluorescent reporters belonging to the green fluorescent 
protein family. 
The thesis is organized as follow: 
• In Chapter 1 I provide a brief review of the biological context of TRPV1, 
namely the cell plasma membrane. This is important for the full 
understanding of biological and biophysical aspects of receptor 
functionality. For this reason I focus on membrane organization with a 
particular regard to all compartments that may be implied in the regulation 
of TRPV1. 
• In Chapter 2 I introduce all the common tools shared by the imaging 
methods that were employed in this thesis work. In particular, the chapter 
presents a short overview on fluorescence microscopy and genetically-
encoded fluorescent proteins. 
Introduction                      3 
• Chapter 3 is the first chapter dealing with my experimental results. There I 
present the study of the binding interactions of the TRPV1 receptor in 
living cells revealed by Förster Resonance Energy Transfer (FRET). A first 
part of the chapter is devoted to a short description of the FRET imaging 
technique, whereas in the second part I describe the FRET analysis to 
reveal that TRPV1 and tubulin mutually interact in the membrane of living 
cells at rest and under agonist stimulation. Conversely, nocodazole-induced 
disassembly of microtubules abolishes the FRET signal, indicating the 
dissociation of TRPV1-microtubule complex. Similarly, FRET analysis 
demonstrates the binding interaction between TRPV1 and caveolin-1 at 
rest. Complementary colocalization studies demonstrate that agonist 
stimulation of the receptor triggers its internalization by caveolar 
endocytosis.  
• In Chapter 4 I show that temporal Image Correlation Spectroscopy (tICS) 
reveals the average temporal dynamics of membrane TRPV1. tICS is a 
method based on the correlation analysis of fluorescence fluctuations 
recorded in the presence of a few moving molecules imaged in a micron-
size area. The general features of tICS are described at the beginning of the 
chapter. Then, I report tICS measurements on TRPV1 alone. I demonstrate 
that, at basal conditions, TRPV1 dynamics comprises two components with 
rather different membrane diffusion (fast- and slow-moving pools). 
Depolymerization of microtubules yields a significant fraction of immobile 
and aggregated receptor. In the last part of the chapter I describe the 
combined use of tICS and FRET to identify and to characterize the receptor 
pool that interacts with microtubules. These experiments show that only the 
slow-moving TRPV1 pool bind to microtubules, at both basal and agonist-
stimulated conditions. 
• In Chapter 5 the oligomerization degree of membrane TRPV1 is 
investigated at basal state or under agonist stimulation. In particular, I 
describe two complementary techniques: fluorescence anisotropy imaging 
(FAIM) associated to homo-FRET, and fluctuation analysis (Number and 
Brightness, abbreviated as N&B). The general aspects of both techniques 
are discussed prior to describe the experimental data. Our results suggest 
that TRPV1 likely exists in both a dimer, immature, form, and a tetrameric 
functional form stabilized by intact microtubules. Microtubules 
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depolymerization leads to significant increase of the oligomerization 
degree of the receptor (and a concomitant reduction of the efficiency as ion 
channel). 
• In Chapter 6 I present a comprehensive description of TRPV1 dynamics 
and microtubule/caveolin interactions obtained by Spatio-Temporal 
Correlation Spectroscopy (STICS). STICS is a fluorescence fluctuation 
technique that permits to quantify both the diffusion regime and its 
quantitative aspects. In particular I applied a novel data interpretation 
approach that has been recently developed at NEST lab: iMSD analysis. 
iMSD is suitable for determining diffusion laws of integral membrane 
proteins in live cells with high temporal and spatial resolution and no need 
for the preliminary assumption of a specific interpretative model. At the 
beginning of the chapter I describe the general aspects of iMSD. Then, I 
focus on the experimental results obtained by applying iMSD to the 
imaging of TRPV1. I demonstrate that basal TRPV1 is mainly split into 
three populations with rather different properties: 1) a fraction binding to 
caveolin-1 and therefore confined in caveolar structures, 2) a fraction 
residing in large, raft-enriched membrane patches whose diffusion is 
actively modulated by microtubules through selective binding, and 3) a fast 
isotropically-diffusing fraction. Remarkably, the last pool shows a non-
negligible correlation between its relative abundance and the cell 
expression level of the receptor. This feature suggests its identification with 
an “immature” form of TRPV1 that acts as “reservoir” of the receptor. In 
light of previous data on endocytic internalization of TRPV1, I interpret the 
binding of TRPV1 to caveolin-1 as a biological means to trigger long-term 
desensitization of the receptor via caveolar endocytosis. It is worth noting 
that the TRPV1 binding to caveolin-1 is reversible with a characteristic 
binding time of several seconds. Conversely, the complex of TRPV1 with 
microtubule does not dissociate within one minute and it appears to move 
within the membrane in rather large patches with 800-900 nm size. This 
system is characterized by a motion actively driven by microtubule chains. 
The "guided" diffusion disappears when microtubules are disassembled. 
These findings support the identification of microtubules as the essential 
modulators of TRPV1 activity. 
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• In Chapter 7 I recast all my data into a model accounting for the molecular 
interplay among TRPV1, microtubules, and caveolin-1. 
• In Appendix A I present the mathematical background of spatio-temporal 
correlation spectroscopy and iMSD analysis.  
• In Appendix B I present a new approach to obtain images of TRPV1 on the 
cell membrane with spatial resolution below the optical diffraction barrier. 
This was made possible by the use of a novel photochromic fluorescent 






1.1 Organization of the plasma membrane and its functional 
role 
According to the fluid mosaic model proposed by Singer and Nicolson in 1972 (1), 
the cellular plasma membrane is a two-dimensional liquid where lipid and protein 
molecules are mixed like a mosaic. Yet, in the last twenty years the fluid mosaic 
model picture of the membrane bilayer has been seriously challenged by many 
experiments. For instance, if the Singer–Nicolson model were true, then membrane 
molecules would always be undergoing simple Brownian diffusion. Several studies, 
however, continue to uncover evidences showing that this is not the case (2). 
Additionally, it is recognized that the plasma membrane is a major platform for 
signal transduction, since it influences how external signals are conveyed into cells’ 
interior by membrane protein receptors. Here, the fluid mosaic model fails in 
describing the weak and dynamic association of membrane proteins into complexes 
involved in signal transduction, as well as their heterogeneous distribution across 
the bilayer. The failure of the Singer-Nicolson model has led to a more accurate 
description of cell membrane, which takes into account the spatial heterogeneity of 
the bilayer.  
The size of membrane domains with functional roles spans from 2 to 300 nm. In 
this spatial scale (usually referred to as mesoscale) the plasma membrane exhibits 
transient hierarchical dynamic substructures, all forming and disassembling with 
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various characteristic times. These mesostructures play key roles in modulating 
signal transduction processes across the membrane. For example, receptor 
oligomerization is enhanced by membrane compartmentalization, since the 
formation of transient protein-protein and protein-lipid complexes generates 
temporary signaling platforms or reaction chambers. This effect is also believed to 
prime the place where the extracellular signal was originally received (for 1 s to 1 
min). Therefore, the comprehension of any molecular signaling process occurring 
across the plasma membrane requires the description of the heterogeneous structure 
of the bilayer. 
Current knowledge identifies three hierarchically-ordered domains at mesoscale, 
which are depicted in Fig. 1.1. Starting from the largest one (first tier), the plasma 
membrane is partitioned into actin membrane-skeleton-induced compartments, with 
size of 40-300 nm. At the second tier in the hierarchy we find raft domains, with 
average size of 2-20 nm. Rafts are generated by the affinitiy between lipids and 
proteins, and their size and composition can be modulated by stimulation of 
membrane receptors (which are in turn involved in signal transduction and 
molecular trafficking). Dynamic protein assemblies of 3-10 nm constitute the 
smallest domains (third tier), although some protein complexes reach few hundred 
nm, as in the cases of clathrin-coated pits. In the following the main features of each 
tier are described in some detail. 
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Figure 1.1. Three-tiered hierarchical structure of mesoscale domains in the plasma 
membrane. (a) Partitioning of the entire plasma membrane by the membrane-associated 
actin-based membrane skeleton (fence) and TM proteins anchored to the membrane skeleton 
fence (pickets). (b) Cholesterol-containing raft domains, with sizes limited by the membrane 
compartments. (c) Dimers and greater oligomers of membrane associated and integral 
membrane proteins, which might exist only transiently. (Adapted from (3)) 
 
 
1.1.1 The first tier: actin membrane-skeleton-induced compartments 
Membrane compartments of 40–300 nm size are created by the interactions of the 
bilayer with actin-based membrane skeleton (fence) and transmembrane proteins 
(TM) anchored to the membrane-skeleton fence (pickets) (Fig. 1.2). In fact, most 
membrane proteins were demonstrated to undergo short-term confined diffusion 
within a compartment and long term hop movement between compartments (hop 
diffusion) (4). This phenomenon is rationalized by the collision of protein 
cytoplasmic domains with the actin-based membrane skeleton, inducing their 
temporary confinement or corralling within the membrane skeleton mesh (Fig. 
1.2A).  
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This “membrane skeleton fence” model is integrated with the presence of 
transmembrane proteins anchored to, and aligned along, the membrane skeleton, 
thereby acting as rows of pickets against the free diffusion of phospholipids (Fig. 
1.2B) (5-7). Notably, the diffusion within any of these compartments (short-range 
diffusion) is as fast as in artificial lipid membranes. Yet, the hop diffusion between 
adjacent compartments accounts for the 20-fold decrease in long-range molecular 
diffusion within plasma membrane as compared to artificial lipid membranes (8). 
1.1.2 The second tier: raft domains  
The plasma membrane is a mixture of several molecules with differing mutual 
miscibility. Some of them associate to yield transient complexes, with sizes and 
lifetimes based on the competition between thermal fluctuations and molecular 
affinities. These transient associations are enhanced by poor molecular miscibility. 
For example, cholesterol is not readily miscible with unsaturated alkyl chains, 
owing to the steric incompatibility between its rigid, bulky tetracyclic sterol 
backbone and the rigid, mandatorily-bent cis-double bonds of the unsaturated 
phospholipids (9-12) (Fig. 1.3 a and b,i). Accordingly, small clusters of several 
cholesterol molecules with lifetimes of 1–100 ns can be observed in unsaturated 
lipid domains (10,12) (Fig. 1.3c).  
In the presence of domains enriched in saturated alkyl chains of 
glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-AR), glycosphingolipids 
and sphingomyelin, a segregation process may take place and cholesterol comes off 
the unsaturated lipid domains to form transient complexes with the saturated alkyl 
moieties. These domains are called lipid rafts and are characterized by a wide range 
of characteristic lifetime, owing to the variability of multi-molecular interactions. 
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Figure 1.2 The membrane-skeleton fence model and the anchored TM protein picket 
model. The left column shows the side view (longitudinal cross-section) of the membrane, 
while the right column shows the bottom view (from the cytoplasm, A) and the top view 
(from outside the cell, B). In the anchored protein picket model (B), the diffusion of 
molecules around immobilized proteins (red region) is slower, owing to the hydrodynamic-
friction-like-effect at the surface of the immobilized protein. This effect could propagate over 
distances equivalent to multiple diameters of picket proteins. When such diffusion barriers are 
aligned along the membrane-skeleton fence, they form effective compartment boundaries. 
(Adapted from (13)). 
 
Each observation method of lipid-rafts is inevitably related to specific time and 
space scales and can therefore probe only limited subsets of rafts among those 
actually occurring in the membrane.  
Cytoskeleton-induced membrane compartments and raft domains coexist in the 
plasma membrane (Fig. 1.1). According to the anchored-protein picket model, the 
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TM protein pickets induce the temporary confinement of phospholipids, GPI-
anchored proteins and TM proteins in the mesh. The TM protein pickets exclude 
cholesterol from the first annulus in the membrane (Fig. 1.3d), owing to the 
structural incompatibility between the TM protein surface and bulky cholesterol 
(9,14). Therefore, the upper size limit of raft domains is slightly less than those of 
membrane compartments segmented by actin cytoskeleton. This limit is particularly 
relevant from a biological point of view, on account of the raft propensity to 
coalesce upon extracellular stimulation (e.g. crosslinking of the ganglioside GM1 by 
the B subunit of cholera toxin (15,16)). 
1.1.3 The third tier: dynamic protein complex domains 
The third tier comprises dynamic assemblies of membrane proteins. The 
stoichiometry of these complexes spans from dimers to oligomers, and they 
associate and dissociate with time constants in the millisecond range. The formation 
of molecular complexes is facilitated by membrane compartments delimited by 
fence and pickets. In fact, once two molecules enter the same compartment, they 
reside there for a long time (1-100 ms) before hop diffusion will displace them 
apart. This phenomenon increases the frequency of binding encounters. Once 
formed, also the molecular complex becomes trapped within compartments. Thus, 
the first tier of membrane organization is tightly coupled to the third tier. A similar 
mechanism accounts for the coupling between the second and third tiers of 
membrane organization (2,17,18). Indeed, ligand-induced GPI-AR homodimers can 
be aggregation nuclei to assemble cholesterol and other saturated lipids. This leads 
to aggregates or transient heterocomplexes with TM scaffolding proteins, a relevant 
feature of downstream signaling (19). According to this molecular framework, 
signal transduction processes are modulated by the interaction of the third tier with 
rafts and cytoskeleton-induced membrane compartments.  
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Figure 1.3 The mechanism by which raft domains are excluded from compartment 
boundaries. (a) Chemical structures of cholesterol, a typical saturated phospholipid (L-α-
distearoylphosphatidylcholine, DSPC), and a typical unsaturated phospholipid (L-α-
dioleoylphosphatidylcholine, DOPC). (b) Non-conformability of the rigid ring structure of 
cholesterol (rectangles) with the rigid, mandatory bend at the C9–C10 cis-double bond in the 
unsaturated alkyl chain (bent rods, i) and with the rough surface of the TM domain of TM 
proteins (ii), which generates vacant pockets (packing defects) in the membrane. In (i), three 
possible configurations placing cholesterol and an unsaturated chain next to each other are 
indicated, but none shows good packing. The TM proteins with raft affinities are expected to 
be well miscible with cholesterol. (c) Schematic snapshot drawings of the membrane domains 
enriched in saturated lipids and cholesterol (i) or unsaturated lipids and cholesterol (ii). Cross-
section (top views) of the membrane are also shown. In the top view, open circles represent 
alkyl chains and solid structures indicate cholesterol molecules (20). Note that cholesterol 
tends to be segregated out of the domains of unsaturated lipids, forming small clusters of 
several cholesterol molecules with lifetimes of 1–100 ns, whereas it mixes with saturated 
lipids, and particularly well at cholesterol:phospholipid molar ratios of 1:1, 1:2 and 1:4. (d) 
Likewise, cholesterol is excluded from the ‘first annulus’ of the TM domain of the picket 
protein, owing to the steric incompatibility as shown in (b,i). (e) The majority of raft domains 
would be contained within a compartment rather than spread across the compartment 
boundaries, because the compartment boundaries are probably formed by cholesterol-
excluding zones (first annular lipids or boundary lipids, shown by diagonal lines) of 1.7–5 nm 
in diameter (surrounding the TM picket proteins) located 2–11 nm away from each other. 
(Adapted from (3)) 
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Importantly, signal transduction is finely tuned by the establishment of multi-
molecular assemblies in/on the plasma membrane, beside the classical bimolecular 
collision or interaction of two protein partners (21-23). In this context, much 
attention is given to the role of coat and scaffolding proteins in signal transduction. 
Coat proteins such as caveolin-1, and scaffolding proteins such as tubulin, were 
recognized to modulate subtly the function of several receptors, including some 
proteins belonging to the TRP family (24,25). Given their relevance in this work, 
the role of caveolin-1 and tubulin in plasma membrane organization and function are 
sketched in the next two paragraphs. 
1.1.4 Caveolae as plasma membrane nanodomains 
Caveolae are submicroscopic, plasma membrane pits with a size of about 60–80 
nm that are abundant in many mammalian cell types. Caveolae are extremely 
widespread and abundant among several cell type, including smooth-muscle cells, 
fibroblasts, endothelial cells, and adipocytes. Caveolae were recognized as relevant 
for endocytosis, transcytosis, calcium signaling, and numerous other signal 
transduction events (26,27). The main structural features of caveolae are 
summarized in Fig. 1.4. The integral membrane protein family of caveolins has been 
the main focus of caveolae research, and caveolins are undisputedly the best 
markers of caveolae since their discovery (28,29). There are three mammalian 
caveolins that form caveolae: CAV1, CAV2 and CAV3. CAV1 and CAV2 are 
generally expressed together in cells other than skeletal muscle, whereas CAV3 is 
predominantly expressed in striated muscle. The fundamental role of caveolins in 
driving membrane curvature of caveolar vesicles was shown by their expression in 
prokaryotic hosts lacking any intracellular membrane systems (30). Furthermore, 
caveolins reside in regions of the membrane whose lipid composition is similar to 
membrane rafts. The relative amount of cholesterol in caveolae may be more than 
100 times higher than the bilayer average, reaching as much as 20,000 molecules in 
immuno-isolated caveolae (31). Some glycosphingolipids (for example, GM1 and 
GM3) and sphingomyelin are also enriched in caveolae as compared to the bulk 
plasma membrane.  
Several receptor proteins, including G protein-coupled receptors (GPCRs) and ion 
channels belonging to the TRP family are known to coexist with caveolin in 
caveolae (32-34). Indeed, one of the most important roles of caveolae is to 
colocalize receptors and effectors within microdomains (35,36). The second 
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important role of caveolae is the internalization via endocytosis, although many 
issues are still controversial in this field (37-39). 
Electron microscopy revealed complex interactions between caveolae and the 
cytoskeleton (40). Microtubules promote trafficking of caveolae forth and back from 
the cell surface. This is thought to occur through local stabilization of microtubules 
by β1 integrins and integrin-linked kinase (ILK) signaling (41). 
 
 
Figure 1.4 Caveolae and caveolins. (A) Caveolin-1 is inserted into the caveolar membrane, 
with the N and C termini facing the cytoplasm and a putative ‘hairpin’ intramembrane 
domain embedded within the membrane bilayer. The scaffolding domain, a highly conserved 
region of caveolin, might have a role in cholesterol interactions through conserved basic (+) 
and bulky hydrophobic residues (red circles). The C-terminal domain, which is close to the 
intramembrane domain, is modified by palmitoyl groups that insert into the lipid bilayer. (B) 
Schematic diagram depicting the caveolin-1 and some receptor and ion channel participating 
in caveolae protein complex formation. (Adapted from (38)) 
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1.1.5 Tubulin and microtubules as modulators of membrane and membrane 
receptors 
Tubulin is an abundant, hydrophilic, heterodimeric protein that is present in all 
eukaryotes. It is the chief component of microtubules, ciliary axonemes, basal 
bodies, and centrioles. The bulk of tubulin consists of a dimeric assembly of two 
similar but not identical subunits, α- and β- tubulin. αβ-tubulin heterodimers are 
protein scaffolds of about 4.6 nm × 8.0 nm × 6.5 nm size (42). The head-to-tail 
association (“polymerization”) of the αβ-tubulin heterodimers yields microtubule 
protofilament. A single microtubule comprises 10–15 protofilaments, each one 
made of dimers that associate laterally to form a 24 nm wide hollow cylinder (43). 
The lateral interaction between subunits of adjacent protofilaments was described as 
a B-type lattice with a seam (long arrow, Fig. 1.5A). A third tubulin isoform, γ-
tubulin, is the template for the correct assembly of microtubules (43). 
Microtubules undergo cycles of rapid growth and disassembly. This is known as 
dynamic instability and was observed both in vitro and in vivo (44,45). Individual 
microtubules do not reach a steady-state length, but exist in either polymerization 
(growth) or depolymerization (shrinkage) states. Notably, the two ends of each 
microtubule chain are characterized by two different growing/disassembly rates. 
This non-equilibrium state depends on the binding of GTP at the nucleotide 
exchangeable site (E site) on β-tubulin during polymerization. The polymerization 
dynamics of microtubules is central to their biological function: (a) microtubules 
can rapidly reorganize in order to differentiate spatially and temporally in 
accordance with the cell context (46), and (b) pushing and pulling forces are 
established during polymerization and depolymerization, respectively (47). 
The interaction of tubulin with biological membranes has been investigated since 
the pioneeristic study of Blitz and Fine forty years ago (48). Tubulin can bind 
directly to membrane lipids, and is called in this case “membrane tubulin”. The 
interaction between the microtubules and the plasma membrane was also confirmed 
by electron microscopy studies (49). The apparent affinity constant measured for 
tubulin-membrane interaction is 1.5-3.0 x 107 M-1 (by observing the tubulin-binding 
affinity of erythrocyte membranes known to be devoid of membrane tubulin (50)). 
This implies that tubulin interaction with the membrane can be observed at 
physiological concentrations within cells. This affinity constant is much lower than 
concentration of tubulin dimers able to trigger polymerization. Additionally, the 
direct interaction of tubulin and/or microtubules with several trans-membrane 
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proteins such as ion channels and G-protein coupled receptors (51) was repeatedly 
assessed. These findings led to the qualitative concept of sub-membranous 
microtubule cytoskeleton. Yet, no general features of tubulin-mediated receptor 
function have been highlighted insofar. 
 
 
Figure 1.5. Microtubules dynamics. (A) Structure of microtubules. (B) Cycle of 
polymerization and depolymerization of microtubules. (Adapted from (43)) 
 
 
1.2 Membrane-modulated neurotransmitter signaling: 
Transient Receptor Potential Vanilloid 1 (TRPV1) 
Recently, several studies highlighted the pivotal role of membrane heterogeneity for 
signal transduction in neurons and other cells of the nervous system (52). 
Coherently with the new hierarchical vision of membrane structure, the most recent 
models of neurotransmission attribute great relevance to the arrangement of 
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signaling molecules in nanodomains to either increase or dampen signaling. In this 
context, some of the most interesting results concern the interplay between lipid 
rafts, coat proteins such caveolins, and cytoskeletal components. This interaction is 
relevant since, in several cases, neurotransmitter signaling is associated with 
cytoskeletal modification (52). This effect provides a feedback to finely tune the 
signaling response, besides affecting the global cell morphology. Actually, tubulin 
and microtubules were early recognized as dynamic partners of many 
neurotransmitters and they are thought to help sequestering and anchoring specific 
neurosignaling proteins in raft domains (53-55). 
The regulating role of membrane heterogeneity appears particularly intriguing 
when receptors that integrate a large number of stimuli come into play. In this 
context, the components of the Transient Receptor Potential (TRP) cation channel 
family are among the most interesting examples of signal integrators that may be 
modulated by membrane features. Beside voltage, TRP channels are activated by a 
wide range of stimuli including intra- and extracellular ligands, temperature, and 
osmotic stress (56). Membrane state, composition, and compartmentalization were 
demonstrated to influence the gating behavior of several TRP channels (57). Some 
members of the TRP family form signal complexes in lipid rafts (32). TRPC1 
(transient receptor potential channel 1) is regulated by caveolin-1, and caveolae 
account for its exocytic trafficking on plasma membrane(58). Phosphatidylinositol 
4,5-bisphosphate (PIP2), a lipid found mostly in raft regions (59), is believed to 
regulate strongly the activation and de-sensitation of many components of the TRP 
family (60).  
Intriguingly, little is known on the interplay between membrane features and the 
Transient Receptor Potential Vanilloid 1 (TRPV1), also known as the capsaicin 
receptor. TRPV1 is a nonselective voltage-dependent cation channel (with 
preference for Ca2+) that is expressed in sensory neurons and in many other cell 
types (e.g. endothelial cells) (61,62). Many studies highlighted TRPV1 as a pivotal 
protein for signal transduction in neurons (63-66), with a specific role in pain 
signaling (nociception) (67). TRPV1 integrates several stimuli, including: pH, heat, 
capsaicin or its analogs, and a variety of lipid metabolites such as anandamide, 
lipoxygenase products and dopamine derivative (68). TRPV1 function is also 
augmented by phosphorylation via protein kinase C downstream of PIP2 hydrolysis 
and diacylglycerol formation (69). Notably, the molecular framework overseeing the 
modulation of TRPV1 function represents a hot topic in biology and biomedicine. In 
fact, sensitization of TRPV1 during chronic pain is associated to the transduction of 
Membrane-modulated neurotransmitter signaling: TRPV1 19 
noxious signaling, and consequently the search for novel anti-pain therapeutics 
addressing TRPV1 is intense. A recent study pointed out that TRPV1 might be 
active only if localized in cholesterol-rich domains of the membrane, presumably 
rafts (70). The connection with rafts was supported by the inhibition of the opening 
properties of TRPV1 by sphingomyelin or gangliosides. Cholesterol depletion by 
incubation with methyl-β-cyclodextrin (MβCD) led to significant decrease of the 
capsaicin-evoked response (70,71). In addition, TRPV1 was found to contain a 
cholesterol-binding site in its membrane-embedded chain (72). Parallel researches 
highlighted the role of TRPV1 in microtubule remodeling, suggesting the presence 
of one microtubule-binding site along the receptor sequence (73,74). Yet, no 
comprehensive picture of the relationships between TRPV1 caveolins/rafts or 
tubulin is available. TRPV1 stands, therefore, as a perfect model of protein signal 
integrator to unveil its subtle modulation by membrane determinants. 
1.2.1 Structure of TRP 
Similarly to voltage-gated K+ channels (Kv), TRPV1 structure comprises six 
transmembrane sections (1–6), with both the N- and C-termini on the cytosolic side 
of the cell membrane (75) and a short, pore-forming hydrophobic region between 
transmembrane section 5 and 6 (Fig. 1.6). Notably, the N- and C-termini of TRPV1 
include “ankyrin” repeats (76) and the ‘oligomerization domain’ (77), respectively. 
 
 
Figure 1.6. A cartoon representation of a single TRPV1 protein, highlighting the six 
transmembrane domains (Adapted from (78)) 
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Single-particle electron cryo-microscopy suggested that TRPV1 assembles into a 
tetrameric complex in reconstructed unilamellar vesicles devoid of native lipid rafts 
(79). This finding is consistent with the biochemical studies in living cells that 
demonstrated a tetrameric stoichiometry for functional TRPV1 (80-82). The 3D 
structure of TRPV1 is 150 Å tall and consists of a smaller domain (~60 Å width and 
40 Å height) embedded into the lipid bilayer, together with an intracellular larger 
domain that forms a basket-like structure (often referred to as “hanging gondola”). 
Within the TRPV1 tetramer, cryo-microscopy clearly identifies two major channel 
regions with respect to the membrane (Fig. 1.7).  
 
 
Figure 1.7. The proposed location of the 3D structure of TRPV1 in the plasma 
membrane. A vertical cut-away view shows the internal mass distribution of the protein. 
(Adapted from (79)) 
 
1.2.2 Function: agonists 
TRPV1 integrates a number of physical and molecular stimuli. Beside voltage, 
modulators of TRPV1 activity include: temperature (83), pH (84) capsaicin and 
capsaicin analogues (Fig. 1.8) (85). 
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Figure 1.8. Chemical structures of selected TRPV1 ligands. Capsaicin, the pungent 
ingredient in hot-chilli peppers; resiniferatoxin, a powerful capsaicin analogue isolated from 
the cactus-like plant Euphorbia resinifera Berg; N-arachidonoyl-dopamine, an endogenous 
lipid mediator in brain nuclei; capsazepine the first generation of TRPV1 antagonist,. 
(Adapted from (86)) 
 
Resiniferatoxin (RTX, Fig. 1.8) is a strong TRPV1 agonist isolated from the latex 
of the perennial Euphorbia resinifera Berg (87). A recent model of TRPV1 structure 
and function proposes a “paddle structure” in which the transmembrane 3 and 4 
regions form a gating paddle, and residues such as 547 constitute an intracellular 
vanilloid-binding site (88). Figure 1.9 shows a simulation of RTX and capsaicin 
bound to TRPV1 in the binding cleft (85). Significantly, activation of TRPV1 leads 
to an increase in the relative permeability to large cations and Ca2+ in dependence of 
time and agonist concentration. Using the substituted cysteine accessibility method, 
these changes were attributed to alterations in the TRPV1 selectivity filter. Thus, 
TRPV1 permeability characteristics are not static, at odds with most ion channels 
(89). 
The dependence of TRPV1 from temperature is particularly interesting. TRPV1 is 
activated upon depolarization, and changes in temperature result in graded shifts of 
its voltage-dependent activation curve. Above 42 °C the receptor is mostly activated 
at resting membrane potential. This thermal sensitivity guarantees prompt cellular 
response to noxious heat (83). Kinetic analysis of gating at different temperatures 
indicates that temperature sensitivity in TRPV1 arises from a tenfold difference in 
the activation energies associated with voltage-dependent opening and closing (90). 
Chemical agonists of TRPV1 work as gating modifiers that potentiate the thermal 
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response. Two possible mechanisms for temperature-dependent channel gating may 
be envisaged on the basis of available data. The channel protein may undergo 
temperature-dependent structural rearrangements, thereby facilitating channel 
opening, or, alternatively, TRPV1 may be able to sense changes in membrane 
tension due to temperature-dependent lipid bilayer rearrangements. In absence of 
agonists, at 37 °C and at a membrane potential of -70 mV (typical of the resting 
state of CHO cells), only a minor fraction of TRPV1 (~ 15%) is in the open form 
(90), consistently with a thermal activation at around 42°C (91). 
1.2.3 Function: antagonists and desensitization  
TRPV1 antagonists fall into two categories: class A antagonists, which block the 
effects of both capsaicin and protons, and class B compounds, which are more 
selective for capsaicin, such as capsazepine 49 (Fig. 1.8). Notably, TRPV1 exhibits 
agonist-induced (acute and tachyphylactic) channel desensitization that should be 
distinguished from de-functionalization of the whole neuron by TRPV1 antagonists. 
This enables the neuron to adapt to specific stimuli by diminishing its overall 
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Figure 1.9. Structural model of RTX (A) and capsaicin (B) interacting with 
transmembrane helices TM3 and TM4 of TRPV1. The backbone of the complete structural 
model along with the side chains of residues considered to be involved in interactions is 
shown. The side chains of Met547, Trp549, and Thr550 are shown as sticks (thick lines). 
Specific interactions of vanillyl moiety with Thr550 and Trp549 are highlighted in the green 
ellipses. Residues considered being involved in interactions with the substituted phenyl 
portions of the two ligands are shown in cyan. Modeled hydrophobic contacts of Tyr511 with 
the hydrophobic ends of RTX and capsaicin are shown. RTX and capsaicin are displayed in 
pink (A) and green (B), respectively. 
 
Several authors highlighted how agonist-induced TRPV1 desensitization is related 
to the increase of intracellular Ca2+, which in turn activates calcineurin and leads to 
de-phosphorylation of TRPV1 (93). Thus, the role of TRPV1 phosphorylation and 
de-phosphorylation is pivotal to the biological function of the receptor. It is accepted 
that TRPV1 can be phosphorylated by several kinases, including PKA, PKC, 
Ca2+/CaM-dependent kinase II (CaMKII) or Src kinase (94).  
Reversal of capsaicin-induced desensitization of TRPV1 is regulated by PKC in 
both sensory neurons and heterologous expression systems (93). TRPV1 has two 
putative phosphorylation sites: S502 and S800. S502 is a non-specific substrate for 
TRPV1 phosphorylation by kinases like PKC, PKA or CAMKII, whereas S800 is a 
specific substrate of PKC. Importantly, S800 is located in the cytoplasmic C-
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terminus of TRPV1 where several regulatory motifs of the receptor can also be 
found. PKC-dependent phosphorylation of Ser800 was demonstrated to potentiate 
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Fluorescence imaging tools 
2.1 Optical sectioning in fluorescence microscopy 
2.1.1 Confocal laser scanning fluorescence microscopy 
Conventional wide-field, epi-fluorescence microscopy offers sub-micrometer 
spatial resolution and excellent temporal resolution (down to a few ms) for the 
observation of biological structures and molecular dynamics in live cells. Epi-
fluorescence microscopes, however, do not have any element other than the 
objective to discriminate between focal plane signal and background fluorescence 
originating from out-of-focal plane fluorophores. This results in a rather blurry 
image when 3D objects, for example cells, are observed (95). This issue was solved 
by the advent of confocal microscopy. In confocal fluorescence microscopy, single 
spot illumination is used while spatially scanning the sample; placing a “pinhole” 
before the detector at a conjugate plane to the illumination focal plane effectively 
rejects out-of-focal fluorescence. A simple schematic of an optical path in a 
fluorescence confocal microscope demostrating this concept is shown in Fig. 2.1. 
Notably, in most applications of confocal microscopy the sample is scanned across 
point-by-point by using a spatially-modulated laser beam (i.e. in a raster fashion): 
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Figure 2.1. A schematic representation of the optical path in a point scanning confocal 
fluorescence microscope. The collimated excitation beam (solid blue) is directed to the 
microscope objective by a dichroic mirror and focused onto the sample. The fluorescence 
signal (dashed blue) emanating from the sample in focus is collected by the same objective 
and imaged through a pinhole onto a detector. The off-focal plane signal (dashed red and 
green) is rejected by the pinhole. Adapted from (95) 
  
The sectioning capability of confocal microscopy yields an improved axial 
resolution over alternative strategies. Resolution here refers to the minimum 
distance between distinguishable objects in an image. Resolution is set by the spatial 
distribution of the light intensity generated and collected by the objective, which is 
called Point Spread Function (PSF). The image of any object is the convolution of 
the spatial feature of the object itself S(x,y,z) with the PSF 
 
 ).,,(),,(),,( zyxPSFzyxSzyxI ⊗=  [2.1] 
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The PSF in confocal systems is usually well approximated by a 3D Gaussian 
distribution (96): 
 



























where 2xyσ  and 
2
zσ  are known as the radial and axial resolutions of the optical 

















σ  [2.4] 
where n is the refraction index of the objective lens and λex is the excitation 
wavelength. For a typical case such as λex = 488 nm, NA=1.2, n=1.33 (water 
immersion objective), we have nm 175=xyσ  and nm 483=zσ . In some cases, the 
Full Width at Half Maximum (FWHM) of the PSF is the parameter of interest; these 
relationships hold for a Gaussian PSF: 
 
 ,)2ln(2⋅= xyxyFWHM σ  [2.5] 
 
 .)2ln(2⋅= zzFWHM σ  [2.6] 
 
2.1.2 Total internal reflection microscopy 
Light propagating through a transparent medium will undergo total internal 
reflection (TIR) when it hits, at an angle greater than a critical value (θc), the 
interface with a second medium with a lower refraction index. Whenever TIR 
occurs, an evanescent field (EF) is generated at the interface and decays 
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exponentially into the second medium (97). This EF can be used to excite 
selectively fluorophores within a distance of a few hundred nanometers from the 
interface, rejecting concomitantly the out-of-focus fluorescence background. This is 
the underlying principle of Total Internal Reflection Fluorescence Microscopy 
(TIRFM). In modern TIRFM setups, the EF is obtained by passing the excitation 
light through an objective lens with a very high refractive index (1.4-1.5) as 
compared to water (the main component of the biological sample). To ensure total 
reflection at the objective-water interface, only a small annulus in the objective 
aperture plane is illuminated, yielding excitation beams that hit at the interface with 
angles > θc (Figure 2.2) (98). On account of its high axial sectioning capability 
(100-250 nm), TIRFM has excelled in the study of cellular organization and 
dynamic processes within or close to the cellular plasma membrane. Notably, in 
TIRFM the laser beam is not scanned across the sample but all the points are excited 
simultaneously, allowing for the use of highly-sensitive CCD detectors (e.g. 
Electron Multiplied CCD). 
 
 
2.2 Genetically-encoded fluorescent probes for live cell 
imaging: autofluorescent proteins 
The discovery of a fluorescent protein taking part in the bioluminescence system 
of jellyfish Aequorea Victoria dates back the early 60s (99). This protein was named 
Green Fluorescent Protein from its bright green fluorescence obtained by UV-blue 
light excitation; hereafter it will be simply referred to as wild-type GFP or wtGFP, 
in keeping with the scientific nomenclature in use. Thirty years later, with the 
cloning of the gene (100) and the demonstration that its expression in other 
organisms still produces fluorescence (101,102), the interest in wtGFP started to rise 
dramatically and eventually led to a revolution in fluorescence microscopy 
bioimaging (103). In the same years, many other fluorescent and non-fluorescent 
GFP homologues were discovered in a variety of organisms (104,105). Additionally, 
protein engineering by sequence mutagenesis has produced several Fluorescent 
Proteins (FPs) with optical properties spanning almost all regions of the visible 
spectrum (106). 
 
Genetically-encoded fluorescent probes for live cell imaging: autofluorescent proteins 29 
 
 
Figure 2.2. TIRFM configuration. Scheme of objective-based TIRFM. For description, see 
text. Adapted from (95) 
 
The singular success of FPs in fluorescence microscopy owes to the genetic 
encoding of fluorescence that does not require any additional cofactor (eg. enzymes) 
from the host organism. This allows for the expression of any fluorescent chimera in 
living cells. FPs do not usually perturb the biological processes of the target protein. 
Hence, FPs represent a nearly perfect bio-nanodevice to unveil cell mechanisms at 
the molecular level (107-109). 
wtGFP is constituted by a peptide chain of 238 aminoacids and 27 kDa molecular 
weight (103). X-ray spectroscopy displayed that this sequence folds in a compact 
cylindrical three-dimensional structure (referred to as β-barrel, Fig. 2.3), laterally-
enclosed by 11-stranded β-sheet, and with a base diameter of 24 Å and a height of 
42 Å (110). Remarkably, all FPs share thus β-barrel fold, regardless of the degree of 
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homology of their primary sequences (107). Differences can be found in quaternary 
structure, since several natural FPs arrange as tightly bound tetramers or dimers, a 
feature that initially hampered their applications. Primary sequence mutagenesis was 





Figure 2.3. 3D structure of wtGFP from X-ray analysis The frontal part of the barrel is 
removed to show the protein chromophore buried at the center of the tertiary structure. 
Adapted from (110). 
 
In wtGFP, the chromophore (Chrom) is a 4-(p-hydroxybenzylidene) 
imidazolinone. Structurally, Chrom is constituted by two conjugated aromatic rings, 
one being a six-member aromatic phenol and the other being a five-member 
imidazolidinone (Fig. 2.4) (103). The alternating single and double bonds in the 
bridge region of Chrom extend the electron delocalization from the phenolate to the 
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carbonyl of the imidazolinone. Accordingly, efficient visible-light absorption takes 
place due to this π-conjugated system. Chrom originates from the post-translational 
autocatalytic modification of three consecutive aminoacids: Ser65-Tyr66-Gly67 
(112,113) (Fig. 2.4). Several FPs share the Chrom structure of wtGFP. Instead, Red 
Fluorescent Proteins (RFPs) are characterized by further post-translational 
processing of the chromophore that leads to more extended electron conjugation. 
 
 
Figure 2.4. Formation of wtGFP chromophore. The cyclization-oxidation-dehydratation 
post-translational processing of the aminoacid triplet Ser65-Tyr66-Gly67. Adapted from (114) 
 
For all FPs sharing the wtGFP Chrom, the phenol group can exist either as neutral 
(protonated phenol) or anionic (deprotonated phenol). The absorption of the neutral 
form (A state) is always significantly blue-shifted with respect to the anionic form 
(B state): indeed, in wtGFP A peaks at 398 nm, whereas B peaks at 475 nm (Fig. 
2.5). The A/B population ratio is around 6/1, and it is nearly unaffected by changes 
of proton concentration in the 5-11 pH range (115). This rather unexpected 
phenomenon was explained by means of the presence of a second ionizable residue 
near the chromophore, namely Glu222, which buffers the chromophore ionization 
(116). 
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Figure 2.5. Optical properties of wtGFP. Normalized absorption (black line) and emission 
of state A (blue line) excited at 405 nm (dashed blue line) and emission of state B (green line) 
excited at 488 nm (dashed green line). 
 
Fluorescence emission of wtGFP was extensively studied at very high temporal 
resolution (117,118). The rigid β-barrel structure is responsible for the significant 
protein fluorescence emission. In wtGFP ΦΑ≈ΦΒ=0.78 (119,120). Photon absorption 
by B leads to excited state B* that has a single emission channel at 503 nm. 
Conversely, upon excitation of A two competing photoprocesses leading to emission 
are triggered: i) direct emission from A* (at 440-480 nm) and ii) Excited State 
Proton Transfer (ESPT) from A* to Glu222 through a proton wire of H-bonds 
involving one water molecules and Ser205 (117,118,121) eventually leading to 507 
nm emission. ESPT takes place in a few picoseconds on account of the strongly 
increased acidity of the phenol group (122), and it represents a much more efficient 
depletion channel of A* than direct fluorescence emission (123). Many other GFP 
variants share these photophysical properties. 
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Five main families of FPs can be identified: blue (BFPs), cyan (CFPs), green 
(GFPs), yellow (YFPs), and red emitting (RFPs). In the following, I shall briefly 
describe the properties of GFPs, YFPs, and RFPs because FPs belong to these 
families were employed in this work. 
 
GFPs. The proteins belonging to this class have optical properties similar to those 
displayed by wtGFP, although in most cases only the bright anionic form of the 
chromophore is optically active. Indeed, the most popular green variant, 
Enhanced Green Fluorescent Protein (F64L/S65T GFP or EGFP) owes its high 
brightness to a predominantly anionic tyrosin-based Chrom (Y-Chrom) above pH 
6 (116,124). In several GFPs (e.g. EGFP), the change of the external pH enables 
the reversible population shift from the neutral to the anionic states of the 
chromophore; this phenomenon is associated with a pH-titration curve clearly 
observable both in absorption and in fluorescence(125). 
 
YFPs. YFPs share an aromatic moiety (from Tyr, Phe, or His) π-stacked to GFP Chrom. 
In this configuration, the excitation and emission energies of Chrom are reduced 
by increasing the polarizability of the environment around the chromophore 
(126). Best results were obtained with T203Y GFPs. Variants EYFP 
(S65G/V68L/T203Y GFP) and 10C (S72A EYFP) display possibly the highest 
extinction coefficients (> 75,000 M-1cm-1), emission quantum yields (Φ > 0.8), 
and fluorescence lifetimes (τ > 3 ns) that can be found in FPs. In most cases, 
YFPs show pH-dependent absorption and fluorescence response, owing to 
chromophore ionization. Additionally, the fluorescence of many YFPs is 
quenched by chloride ion, on account of a binding equilibrium with dissociation 
constant > 10 µM at physiological pH (127-131). 
 
RFPs. As already stated, the strong red-shift of RFPs compared to wtGFP is mainly 
attributable to the enlargement of the π-conjugated system by the additional 
double bond. Representative RFPs display absorption shifts from +71 to +133 
nm, and emission shifts from +54 to +142 nm, compared to the B state (anionic) 
of wtGFP (Table 1). Additionally, the anionic chromophore is the prevalent form 
in the 5-9 pH range. Interestingly, many RFPs display deviation from coplanarity 
of the two aromatic rings in the protein chromophore, resulting in a reduced 
quantum yield of fluorescence. As an example, the widely-used mCherry variant 
is characterized by a particularly distorted chromophore and a rather low 
fluorescence quantum yield (0.22) (109). For high-sensitivity imaging, a much 
better choice is represented by TagRFP, a monomeric red (orange) fluorescent 
protein generated from the wild-type RFP from sea anemone Entacmaea 
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quadricolor (132). It possesses bright fluorescence (Φ=0.66 (133)) with 






Binding interactions of TRPV1 in living cells 
Recent literature data highlighted that, besides acting as a ligand-gated voltage-
dependent ion channel, the TRPV1 receptor could participate to a complex network 
of binding interactions at cell membrane level. For instance, colocalization 
measurements in fixed cells suggested that microtubules could represent binding 
partners of TRPV1. The relevance of this interaction stems from the observed 
disassembly of microtubules, and possible cytoskeletal remodeling, upon receptor 
activation. Additionally, the clathrin-independent endocytotic mechanism that 
underlines the TRPV1 long-term desensitization evokes the binding interaction of 
the receptor with biomolecules involved in vesicular trafficking.  
In this chapter we demonstrate for the first time in living cells that the TRPV1 
receptor effectively binds to both microtubules and caveolin-1, the latter being the 
molecular hallmark of caveolar internalization mechanism. Notably, our results are 
based on Fluorescence (Förster) Resonance Energy Transfer (FRET) measurements. 
Indeed, FRET is among the most efficient techniques to reveal biomolecular 
complexes in living cells. For this reason, section 3.1 is devoted to a comprehensive 
description of FRET imaging. Sections 3.2 and 3.3 report on the interaction between 
TRPV1 and integer microtubules and caveolin-1, respectively. The experimental 
procedures are described in section 3.4. 
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3.1 Imaging biomolecular interactions: Fluorescence (Förster) 
Resonance Energy Transfer (FRET) 
3.1.1 General description 
Fluorescence (Förster) Resonance Energy Transfer (FRET) is a spectroscopic 
technique easily implementable in fluorescence microscopy that is ideally suited to 
study biomolecular interactions in solution, live cells, and tissues (134). FRET is 
based on the non-radiative transfer of energy from an excited molecular fluorophore 
(donor, D) to a chromophore (acceptor, A) via long-range dipole-dipole coupling 
(135). A necessary condition for FRET is the partial overlap of the emission 
spectrum of D with the absorption spectrum of A, to ensure conservation of energy 
in the non-radiative exchange process (Fig. 3.1). 
 
Figure 3.1. FRET mechanism. (A) Illustration of the overlap between the emission spectrum 
of the donor and the absorption of the acceptor. (B). Energy level scheme of donor and 
acceptor molecules showing the coupled transitions in the case where vibrational relaxation is 
faster than energy transfer (very weak coupling).  
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In most applications the acceptor is fluorescent, although this is not required for 
FRET to take place. According to Förster’s theory (135,136), the rate of energy 


















where 0Dτ  is the emission lifetime of D in absence of acceptor, FRETτ  is the time 
required for the energy transfer to take place, r is the separation between D and A, 
and R0 (Förster radius) is the distance at which transfer and spontaneous decay of 
the excited D are equally probable ( FRETD ττ =
0 ). R0 can be determined from 
spectroscopic data, following: 
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where κ2 represents the angle between the two transition dipoles of D and A, ΦD is 
the donor quantum yield, and J(λ) is the so-called spectral overlap integral between 
D and A (135): 
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In Eq. 3.3 ( )λDF  is the area-normalized emission spectrum of the donor and ( )λε A  
is the molar absorption spectrum of the acceptor.  κ2 modulates deeply FRET 
emission. Its values can range between 0 and 4. A value of 0 corresponds to a 
perpendicular orientation of donor and acceptor transition dipole moments, yielding 
no FRET. A value of 4 corresponds to a collinear orientation between the two 
dipoles, leading to maximal FRET. If the fluorophores possess complete rotational 
freedom, the statistical average over all sampled orientations leads to κ2=2/3 (137). 
This value is typically used for the calculation of R0 of FRET pairs. Yet, great care 
must be taken whenever steric restrictions could invalidate the above assumption.  
Good D/A couples are characterized by a large overlap integral associated with R0 
in the 3-10 nm range. Accordingly, FRET requires nm-scale proximity between 
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molecules for a time comparable to the emission lifetime of donor, i.e. in the ns 
range (see Eq. 3.1). This combination is possible only when D and A are engaged in 
a complex or they are confined close to each other by the surrounding matrix. In 
fact, pure statistical collisions would take place in ps time scale or shorter, not 
allowing FRET to take place. Conventionally, FRET is measured through its 
“efficiency” (E), i.e.: 
 
















Quantitative determination of E, combined with knowledge of R0 for the D/A 
couple would provide structural information on the distance between the binding 
partners (eq. 3.4). It is worth noting the steep dependence (inverse of sixth power) of 
E from the distance r (Fig. 3.2) that makes E exquisitely sensitive to the separation 
among the partners. Accordingly, FRET provides a tools for resolving molecular 




Figure 3.2. Distance-dependency of FRET-efficiency. 
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3.1.2 FRET via sensitized emission 
In the last twenty years FRET has been widely applied to probe interactions 
among biomolecules (139). Several methods were proposed to combine FRET with 
fluorescence imaging, in view of obtaining maps of FRET efficiency at submicron 
scale (140).  
In principle, E could be obtained in each pixel from the ratio of D fluorescence in 













E -1  [3.5] 
The main drawback of ratio-imaging FRET is its inability to correct for D cross-
talk (i.e. D emission at A emission wavelength) and acceptor bleed-through (non-
FRET residual A excitation at D excitation wavelength). Cross-talk and bleed-
through are particularly severe for D/A couples with extensive spectral overlap. In 
order to remove these two spurious contributions, two correction coefficients α and 
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where exDλ  = D excitation wavelength, 
em
Dλ  = D emission wavelength interval,  
ex
Aλ
=A excitation wavelength, emAλ  = D excitation wavelength interval. α and β can be 
calculated by inspecting samples containing only the acceptor and the donor, 
respectively. 
In samples containing both A and D, FRET emission is measured in the ( )emAexD λλ ,  
setting and then corrected according to: 
 
 ( ) ( ) ( ) ( ).,,,, emDexDemAexAemAexDemAexD FFFcorrF λλβλλαλλλλ −−=  [3.7] 
Then, an apparent FRET efficiency E is calculated upon normalizing 
( )emAexDcorrF λλ ,  by either D or A emission. For donor normalization we have: 
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It can be easily demonstrated that EEapp =  for )()( exD
ex
A II λλ =  and/or α=0, 
where I stands for excitation intensity. Even if these conditions do not apply, Eapp is 
a robust estimate of E whenever donor and acceptor excitation intensities are of the 
same order of magnitude.  
3.1.3 Optimized fluorescent proteins as FRET couples 
Fluorophores for FRET must fulfill a number of criteria. First the spectral overlap 
between donor fluorescence and acceptor excitation wavelengths should be as large 
as possible. Additionally, the donor and the acceptor should be associated with large 
quantum yields and extinction coefficients. In recent years, a considerable effort was 
devoted to developing fluorescent protein couples for FRET. In particular, the 
engineering of new bright and photostable RFPs allowed the use of popular GFP 
and YFP variants as donors in GFP/RFP or YFP/RFP FRET couples. 
Among RFP acceptors, an excellent choice is represented by TagRFP, a 
monomeric red fluorescent protein derived from the wild-type RFP extracted from 
sea anemone Entacmaea quadricolor (132). It possesses bright fluorescence 
(Φ=0.66 (141)) with excitation/emission maxima at 555 and 584 nm, respectively 
(Fig. 3.3). TagRFP displays good R0 values in tandem with popular EGFP and YFP 
variants (Fig. 3.3). For these reasons TagRFP was selected as common acceptor 
partner in all FRET measurements carried out in this thesis. 
As for donors, an interesting member of GFP family is E0GFP. E0GFP differs 
from wtGFP for the F64L mutation, which increase the folding efficiency such as in 
EGFP (142), and the silent mutation H231L. Very much alike to wtGFP, E0GFP 
displays: 1) a major absorption peak at 400 nm and a minor peak at 476 nm 
corresponding to the protonated and the anionic forms of the chromophore (Fig. 
3.3), respectively; 2) efficient ESPT upon 400 nm excitation, yielding green light 
peaked at 508 nm with Φ=0.6 (143). This pronounced Stokes shift (108 nm, 5315 
cm-1) can be exploited for FRET measurements with TagRFP acceptor. Indeed, this 
couple is associated with a large separation between donor and acceptor excitation 
frequencies and a negligible acceptor bleed-through (Fig. 3). Minimizing bleed-
through in FRET couples is necessary to avoid cumbersome data manipulation in 
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sensitized emission measurements. E0GFP displays a large Forster radius when 
coupled with TagRFP (5.4 nm) and α < 1%. 
 
 
Figure 3.3. Spectroscopic properties of typical FRET pairs. (A) Normalized absorption 
(solid lines) and emission (dashed lines) of E0GFP (green) and TagRFP (red). (B) Normalized 
absorption (solid lines) and emission (dashed lines) of EGFP (green) and TagRFP (red). (C) 
Normalized absorption (solid lines) and emission (dashed lines) of YFP (yellow) and TagRFP 




3.2 Detection of TRPV1 interactions with microtubules 
Recently, a few groups demonstrated the interaction of TRP channels with 
microtubule cytoskeleton (144-146). Using tests on fixed cells, as well as 
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biochemical essays, the interaction of TRPV1 with tubulin dimer was proposed and 
attributed to two short sequences in the cytoplasmic tail of the receptor 
(73,147,148). To shed light on the putative interaction between microtubule and 
TRPV1, we carried out sensitized emission FRET measurements in living cell. Our 
results are described and discussed in the following sections. 
3.2.1 Localization and functionality of transiently transfected TRPV1-FP 
chimeras 
For the imaging studies reported in this section and, more generally, in the whole 
thesis work, we prepared a toolbox of TRPV1 chimeras with different FPs, namely: 
E0GFP and EGFP (green), YFP (yellow), and TagRFP (red). The first three 
constructs were prepared from a common plasmid by several runs of single-point 
mutagenesis; TRPV1-TagRFP was obtained by cloning the TRPV1 sequence into a 
commercial plasmid expressing TagRFP. In all the experiments, TRPV1 was 
transiently expressed and imaged in Chinese Hamster Ovary cells (CHO) because 
this line does not express endogenously the TRPV1 channel. 
TRPV1 at basal state showed non-homogeneous localization in the plasma 
membrane (Fig. 3.4) and in the ER. Previous reports on fixed cells indicated similar 
localization patterns (149). Likely, the heterogeneous distribution of TRPV1 is 
relevant for its biological function. The nature of FP reporter did not affect the 
TRPV1 distribution (Fig. 3.4). 
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Figure 3.4. TRPV1 localization. CHO K1 transfected with TRPV1-E0GFP (A), TRPV1-
EGFP (B), TRPV1-YFP (C) and TRPV1-TagRFP (D) imaged by using confocal microscopy 
(A and C) or TIRFM (B and D) 
 
Next, we tested the ion channel functionality of the TRPV1-FP constructs. In 
particular, we assessed the ability of the labeled receptor to activate inward calcium 
flux upon RTX stimulation at 20 nM.. This concentration was selected because it 
ensured full saturation of membrane receptors while preserving cell viability (EC50 
of RTX is 0.15 nM (150)). The variations of intracellular calcium were monitored 
by the fluorescent indicator Calcium Crimson. Similarly to what observed for 
physiological TRPV1 (150), RTX induced a gradual increase of intracellular Ca2+ 
that leveled off about 100 s after administration (Fig. 3.5).  
 
44                                                           Binding interactions of TRPV1 in living cells 
 
Figure 3.5 TRPV1 functionality. Calcium signals registration in cell upon activation by 
RTX at 20 nM concentration.. The arrow indicated the time when RTX is added. 
 
Accordingly, in this thesis work all the subsequent biophysical measurements that 
entailed receptor activation were carried out after an induction time of 100 s. 
3.2.2 Effect of microtubules disassembly on TRPV1 activation  
To verify the effect of microtubule integrity on TRPV1 activation, we tested the 
receptor functionality upon treatment with 10 µM nocodazole. This concentration 
affords the total disassembly of microtubules after 1-5 minutes from administration, 
as clearly showed by the radical change of the fluorescence pattern given by 




Figure 3.6 Effect of nocodazole administration on microtubules. (A) Microtubules show 
typical filament structure at basal state. (B) Microtubule disassembly results in a rather 
homogeneous distribution of fluorescence. 
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The concomitant effects of nocodazole and RTX agonist were assessed by 
measuring the change in intracellular calcium concentration by following an 
imaging procedure analogous to that reported in §3.2.1 (Fig. 3.7). 
Notably, disassembly of microtubules decreased the maximum amplitude of Ca2+ 
concentration by about 40% and they slowed significantly the influx kinetics. 
Therefore, microtubule integrity is relevant for TRPV1 functionality. This 
conclusion is specular to the recognized role of TRPV1 activation in promoting 
microtubule remodeling through disassembly (25). This effect suggests that a 
complex molecular interplay holds for TRPV1 and microtubules.  
 
Figure 3.7 Calcium signals registration after RTX administration in cells expressing 
TRPV1-YFP. Plot of fluorescence variation of calcium crimson following RTX 
administration to cells, treated with (red curve) and without (blue curve) nocodazole. Each 
curve represents the average of ten acquisitions and for each point the standard deviation is 
reported.  
 
3.2.3 FRET imaging of TRPV1-microtubule binding 
Literature data on the binding interaction between TRPV1 and microtubules are 
based on in vitro biochemical assays (73) and colocalization analysis on fixed cells 
(151). In this thesis the binding interaction between TRPV1 and microtubules was 
explicitly imaged by FRET in the membrane of living cells. FRET measurements 
were carried out in CHO cells co-expressing TagRFP-α-Tubulin (TagRFP-αT) as 
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acceptor and TRPV1-E0GFP or TRPV1-EGFP or TRPV1-YFP as donor. Inspection 
of Fig. 3.3 highlights that all FRET couples are associated with negligible levels of 
cross-talk/bleed-through when FRET emission is collected above 600 nm and donor 
excitation below 490 nm takes place. All couples are characterized by large Forster 
radii (Fig. 3.3), as calculated under the assumption of free mutual rotation of 
transition dipoles (κ2 = 2/3, § 3.1.1). Large R0 values allow for FRET detection over 
large inter-protein distances such as those expected when one or both partners are 
multimeric receptor proteins. Accordingly, the sensitized emission mode of 
measuring FRET (§ 3.1.2) was adopted.  
At first, confocal imaging experiments were carried by using TRPV1-E0GFP or 
TRPV1-YFP as donors, and TagRFP as acceptor. Remarkably, significant FRET 
emission was revealed in the membrane of cells in basal state. Both couples yielded 
similar donor-normalized Eapp: 0.25±0.03 for TRPV1-E0GFP/TagRFP-αT (10 cells) 
and 0.27±0.03 for TRPV1-YFP/TagRFP-αT (20 cells). From Eq. 3.4, these figures 
indicate a 6.5-7.0 nm distance between FP chromophores. Taking into account the 
size of the FP β-barrel (2-2.5 nm), one can calculate a 5-6 nm distance between 
TRPV1 and α-tubulin. 
 
 
Figure 3.8 FRET measurements on cells expressing TRPV1-YFP and TagRFP-αT. Left 
panels: donor emission images (λexc= 488 nm λem= 500-530 nm); middle panels: acceptor 
emission images (λexc= 561 nm λem= 600-640 nm): right panels: maps of donor-normalized, 
apparent FRET efficiency (λexc= 488 nm λem= 600-640 nm).  
 
We should stress that these results are compatible with TRPV1 binding to either 
component of α,β-tubulin dimers, since each dimer has an average size of 
4.6x8.0x6.5 nm. Nonetheless, previous biochemical assays suggest that TRPV1 
more preferably interacts with β-tubulin.  
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Figure 3.9. FRET measurements on cell expressing TRPV1-E0GFP and TagRFP-αT. 
Left panel: donor (TRPV1-E0GFP) emission image (λexc= 405 nm, λem= 500-530 nm); middle 
panel: acceptor (TagRFP-αT) emission image (λexc= 561 nm λem= 600-640 nm); right panel: 
FRET map of donor-normalized apparent FRET efficiency (λexc= 405 nm λem= 600-640 nm). 
 
The membrane localization of binding interaction was confirmed by sensitized 
emission FRET experiments carried out in TIRF mode (Fig. 3.9). Interestingly, 
TIRF-FRET images highlighted the existence of 500-1000 nm-domains where the 
binding interaction was prevalent. 
 
 
Figure 3.10. FRET imaging of TRPV1-microtubules interaction. Upper left panel: donor 
emission image; upper right panel, acceptor emission image; lower left panel, donor-
normalized apparent FRET image; scale bar: 5 µm. Lower right: zoom of a region of the 
FRET image; scale bar: 1 µm. 
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Sensitized emission FRET images pointed out that receptor stimulation had no 
effect on the complex (Eapp=0.26±0.06, YFP/TagRFP couple, 10 cells). Vice-versa, 
nocodazole treatment led to complete disappearance of FRET. This finding supports 
the notion of direct interaction with microtubules, i.e. binding between TRPV1 and 




Figure 3.11. FRET measurements on cells expressing TRPV1-YFP and TagRFP-αT 
upon RTX or nocodazole administration. Left panels: donor emission images (λexc= 488 
nm λem= 500-530 nm); middle panels: acceptor emission images (λexc= 561 nm λem= 600-640 
nm): right panels: maps of donor-normalized apparent FRET efficiency (λexc= 488 nm λem= 
600-640 nm.  
 
 
3.3 TRPV1 interaction with caveolin-1 
Sanz-Salvador et al. (152) reported that agonist exposure of DRG neurons and 
TRPV1-expressing cells promotes receptor endocytosis and down-regulation 
through lysosomal degradation. This process requires Ca2+ entry and appears 
mediated by an endocytotic mechanism that is clathrin-independent. Caveolar 
endocytosis represents a major internalization pathway of membrane proteins and it 
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is clathrin-independent (153). As already stated at §1.14, caveolin-1, the main 
structural protein in caveolae, plays a crucial role in the membrane localization of 
several members of TRP family (24,154,155). Furthermore, caveolae-enriched 
regions of the membrane usually coincide with raft domains (156). Lipid rafts are in 
turn the preferential membrane locations of TRPV1 (70). Thus, we hypothesized 
that TRPV1 activity could be connected to caveolin-enriched membrane regions and 
their endocytotic pathway. In this framework, caveolar endocytosis could be 
responsible for TRPV1 down-regulation after activation. Accordingly, we set out to 
determine if caveolin-1 and TRPV1 mutually interact.  
3.3.1 FRET imaging of TRPV1-caveolin-1 binding 
The existence of molecular interaction between TRPV1 and caveolin-1 was 
investigated by colocalization and sensitized emission FRET. Measurements were 
carried out in CHO cells transiently expressing TRPV1-TagRFP and caveolin-1-
EGFP. At first, we tested the colocalization of the two proteins at basal state and 
after agonist stimulation. At basal state, caveolin-1-EGFP and TRPV1-TagRFP 
showed limited colocalization in the internal regions of CHO cells (Fig. 3.12), as 
witnessed by the value of Pearson coefficient <r> = 0.47±0.05 (average of #5 cells). 
We should remind that positive colocalization holds for r ≥ 0.5 (157). 
Yet, a few minutes after agonist administration, caveolin-1-EGFP was found to 
colocalize, although not completely, with TRPV1-TagRFP (<r> = 0.70±0.09, #10 
cells) in intracellular regions that should be identified as caveolar vesicles and 
caveosoma (Fig. 3.12). This finding suggests a role for caveolin in the control 
(through internalization) of membrane TRPV1 concentration following agonist 
stimulation. The statistical difference between basal and activated states was 
confirmed also by t-test between the two relevant datasets, for which we calculated 
p < 10-4.  
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Figure 3.12. Colocalization experiments between caveolin-1-EGFP and TRPV1-TagRFP 
inside the cells. Colocalization between caveolin-1-EGFP and TRPV1-TagRFP in CHO cell 
before (upper panels) and after RTX administration (lower panels). 
 
To determine whether caveolin-1 and TRPV1 bind at membrane level in basal 
condition, we performed sensitized emission FRET experiments (§ 3.1.2) on the 
caveolin-1-EGFP/TRPV1-TagRFP couple in TIRF configuration. Excitation was set 
at 488 nm and FRET emission was collected above 600 nm. In this spectral 
configuration negligible spectral cross-talk and bleed-through (<4%) affect the 
FRET measurements (§ 2.2.2). Consequently, photons collected in the acceptor 
channel upon donor excitation were attributed to FRET alone. Remarkably, we 
obtained a positive sensitized-emission FRET signal, which witnesses protein-
protein binding. 
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Figure 3.13. FRET imaging of TRPV1-microtubules interaction. Left panel, donor 
emission image; middle panel, acceptor emission image; right panel, donor-normalized 
apparent FRET efficiency. 
 
Quantitatively, we recorded E = 0.38±0.05 (10 cells). From Eq. 3.4, this value 
afforded a 5.7 nm distance between FP chromophores, which in turn suggests a 3-
3.5 nm distance between TRPV1 and caveolin-1 by removing the contribution of the 
FP β-barrel (§3.2.2). TIRF-FRET images highlighted the existence of 200-300 nm 
“confined” regions where the binding interaction takes place (Fig. 3.14).  
 
 
Figure 3.14. Zoom of cell region on FRET imaging between caveolin-1-EGFP and 
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3.4 Experimental procedures 
3.4.1 Engineering of labeled-TRPV1 vectors 
We constructed a series of GFP-mutant of TRPV1 for FRET measurements with 
commercial plasmids target to microtubules and caveolin-1. The expression vector 
TRPV1-E0GFP was generated by site-direct mutagenesis of p-TRPV1- EYQ1 (158) 
using the following primers:  
Y203T:  5’- CAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAA-3’ 
Q222E:5’-CGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGG-3’  
For the construction of the plasmid encoding for TRPV1-EGFP chimera was 
generated by site direct mutagenesis of p-TRPV1-E0GFP (described in ref.(145)) 
using the following primer: 
S65T: 5’-GTGACCACCCTGACCTACGGCGTGCAGTGCTTC-3’ 
The TRPV1-TagRFP plasmid was constructed by cloning TRPV1 from TRPV1-
YFP (a kindly gift from Wei Cheng, Department of Physiology and Membrane 
Biology, University of California, Davis, CA) and its activity upon transfection was 
tested according to Ref. (159). We performed a cut and paste cloning by using 
HindIII-SmaI sites on TRPV1-YFP plasmid and TagRFP vector (provided by 
Evrogen). Then we inserted the TagRFP fragment into plasmid encoding for 
TRPV1. An additional round of single point mutation was performed for remake the 
TagRFP gene in frame. 
3.4.2 Cell culture and transfections. 
Transfections of all constructs were performed in CHO K1 cells. CHO K1 were 
provided from the American Type Culture Collection (CCL-61 ATCC) and were 
grown in Ham’s F1”K medium supplemented with 10% of Fetal Bovine Serum at 
37°C and in 5% CO2. Transfection of all constructs was carried out using 
Lipofectamine reagent (Invitrogen,) according to the manufacturer's instructions. 
For live imaging cells were plated 24h before transfection onto 35-mm glass bottom 
dish (WillCo-dish GWSt-3522) 
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3.4.3 Fluorescence imaging by confocal laser scanning microscopy (CLSM) 
and by Total Internal Reflection Fluorescent microscopy (TIRFM) 
Cell fluorescence was analyzed using a confocal microscope Olympus FluoView 
1000-ASW-2.0 (Japan) or a Leica TCS SP2 both equipped with an Ar-Laser for 
excitation at 458, 476 (only for Leica SP2) 488 and 514 nm and with a HeNe-laser 
for excitation at 543, 561 (only for Leica SP2) and 633 nm. A diode laser was used 
for excitation at 405 nm. Glass bottom Petri dishes containing transfected cells were 
mounted in a thermostated chamber and viewed with a 63x 1.4 NA planApo oil-
immersion objective (Olympus) or 40x 1.25 NA oil-immersion objective (Leica) 
while setting the confocal pinhole at 1 Airy unit.  
Cell membrane fluorescence was analyzed using a Leica AF6000 microscope in 
total internal reflection fluorescence mode, with a penetration depth of the 
evanescent wave below 100 nm. Images were acquired by laser-exciting the green-
emitting fluorophores at 488 nm and the red-emitting TagRFP at 561 nm. In all 
cases, a 100x oil-immersion objective (NA 1.47) was employed. Fluorescence 
detection was ensured by a cooled EM-CCD Hamamatsu C1900-13. Glass bottom 
Petri dishes containing transfected cells were mounted in a thermostated chamber. 
 Live cell imaging was always performed at 37°C in a 5% CO2 atmosphere. 
3.4.4 Cell calcium measurement.  
The fluorescent calcium indicator Calcium Crimson was adopted for all the 
measurements. The fluorescence indicator was dissolved in Pluronic F-127 to 
facilitate cell loading. We added the Pluronic solution to cells kept in PBS buffer to 
obtain a final loading concentration of 10 µM. Then we incubated the cell with the 
indicator at room temperature for 1 hour. The effect of receptor activation was 
evaluated by CLSM by exciting at 545 nm and collecting the emission in the 560-
660 nm wavelength range. Temporal stacks were acquired with 1 s frame rate in 
both basal and agonist-stimulated conditions. 
3.4.5 FRET measurements and data analysis. 
FRET measurements between TRPV1-E0GFP or TRPV1-TagRFP and TagRFP-
αT were carried with a Leica TCS SP2 inverted confocal microscope (Leica 
Microsystems AG, Wetzlar, Germany). 63x (NA 1.4) planApo oil immersion 
objectives were used while setting the confocal pinhole at 1 Airy unit. FRET was 
performed by the sensitized emission technique under 488 nm for donor TRPV1-
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YFP excitation and 405 nm for donor TRPV1-E0GFP. Fluorescence emission of the 
RFP-αT acceptor was detected at 600-640 nm.  
FRET imaging between caveolin-1-EGFP and TagRFP-αT was carried out by a 
Leica AF6000 fluorescence microscope in Total Internal Reflection mode (TIRFM), 
with a penetration depth of the evanescent wave less than 100 nm. Fluorescence was 
collected by using a 100x (NA 1.47) oil-immersion objective and was recorder 
cooled EM-CCD (Hamamatsu C1900-13). Acquisition settings were as in the 
following: in cell co-transfected with TRPV1-TagRFP and caveolin-1-EGFP we 
excited EGFP (donor) at 488 nm and we collected the RFP emission (acceptor) at 
604-620nm and 660-679 nm. FRET analysis was carried out with a custom-made 
plugin of the ImageJ software (145) 
3.4.6 Colocalization experiments.  
Imaging was carried out with a Leica SP5 inverted confocal microscope. 40x (NA 
1.25) planApo oil immersion object was used while setting the confocal pinhole at 1 
Airy unit. Excitation of caveolin-1-EGFP was performed at 458 nm and 
fluorescence emission was collected in the range 470-520 nm. Excitation of 
TRPV1-TagRFP was performed at 561 nm and fluorescence emission was collected 








Temporal Image Correlation Spectroscopy: 
temporal dynamics of TRPV1 and TRPV1-
microtubule complex on membrane 
In chapter 3 we demonstrated by FRET the binding between membrane TRPV1 
and tubulin dimers belonging to integer microtubule protofilaments. FRET, 
however, offers a still picture of this interaction and does not provide details on the 
interplay between TRPV1 diffusion and binding. To address this point, in this 
chapter we investigate the average diffusion properties of TRPV1 on the membrane 
by temporal Image Correlation Spectroscopy (tICS). tICS is a correlation technique 
particularly suitable for measuring average dynamic properties of membrane 
proteins (160-162),. The theoretical background of tICS is sketched in section 4.1. 
In section 4.2 we demonstrate that membrane TRPV1 is subdivided in at least two 
components, which differ significantly in terms of average diffusion rates. The 
slower component is identifiable with the functional receptor, since it becomes 
predominant upon agonist stimulation. Finally, in section 4.3 we combine tICS with 
FRET to unveil the average diffusion properties of the complex between 
microtubules and TRPV1. By this strategy we demonstrate that only the slower 
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receptor pool does interact with microtubules. This finding links unequivocally the 
functional state of the receptor with microtubule binding.  
 
 
4.1 Correlation spectroscopy: general concept and application 
to imaging 
In the last decades, a remarkable progress in the comprehension of dynamics and 
interactions of fluorescently-labeled biomolecules was brought about by 
Fluorescence Correlation Spectroscopy (FCS) (163). FCS monitors the spontaneous 
fluctuations of fluorescence intensity arising from any process that changes the 
number or brightness of fluorophores in a very small volume. Fluctuations are 
produced by molecular transit across the observation volume and/or any chemical 
reaction that modifies the photophysical properties of the fluorophores (Fig. 4.1). 
The observation volume must be small in order to contain only a few fluorophores 
at a time, thus limiting dynamic averaging effects that would damp fluctuation 
intensities (164). An observation volume of about 1 femtoliter (fl) can be produced 
by focusing a laser beam through a high numeric aperture objective and collecting 
the emitted fluorescence through a pinhole, as realized in confocal microscopy 
setups (Fig. 4.1). A volume of 1 fl would contain on average one molecule at any 
time when the solution concentration is about 60 nM. In FCS the diffusion dynamics 
is recovered by calculating the autocorrelation of fluorescence emission, in order to 
reveal the recurrence of intensity fluctuations in the time domain. 
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Figure 4.1: Fluorescence Correlation Spectroscopy. (Left) Experimental setup for FCS. (a) 
A laser beam is first expanded by a telescope (L1 and L2), and then focused by a high-NA 
objective lens (OBJ) on a fluorescent sample (S). The epifluorescence is collected by the 
same objective, reflected by a dichroic mirror (DM), focused by a tube lens (TL), filtered (F), 
and passed through a confocal aperture (P) onto the detector (DET). (b) Magnified focal 
volume (green) where the sample particles (black circles) are illuminated. (Right) (c) A 
typical fluorescence signal, as a function of time. (d) Portion of the same signal in panel c, 
binned, with an expanded time axis and average fluorescence <F(t)>. The signal is correlated 
with itself at a later time (t+τ) to produce the autocorrelation G(τ). (e) Measured G(τ) 
describing the fluorescence fluctuation of molecules due to diffusion as observed by FCS. 
Adapted from (165) 
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A natural evolution of the FCS concept is represented by Image Correlation 
Spectroscopy (ICS) (166). In ICS, a spatiotemporal autocorrelation function is 
calculated from images of fluorophores collected through either a confocal scanning 
microscope (where detectors are photomultipliers or avalanche diodes) or a TIRF 
microscope (where detectors are highly-sensitive CCD cameras). The introduction 
of the spatial dimension in the calculus of the autocorrelation helps to identify 
spatial structures and characteristics of diffusion that otherwise would not be 
noticed. Notably, ICS reveals only dynamic processes occurring in a time window 
comparable or slower than the frame rate. Modern confocal and TIRF microscopes 
allow fast acquisition rates of about 1-30 milliseconds. ICS-based techniques are 
largely applied to follow diffusion processes occurring in this time-scale, 
particularly on the membrane (167). 
It is worth noting that meaningful interpretation of autocorrelation data is based 
on a strong assumption that is seldom stated in the descriptions of fluorescence 
correlation spectroscopies: the observed system should be space and time-invariant 
(168). At first sight, this condition could appear inapplicable to living systems, 
owing to their constant modification. Nevertheless, FCS/ICS measurements on 
biological samples are usually restricted to small spatial regions and they last for 
times not exceeding a few seconds (169). In most cases, the latter conditions ensure 
nearly “stationary state” for all visible processes occurring in the same regions and 
over the same collection time. 
4.1.1 Temporal Image Correlation Spectroscopy 
Temporal Image Correlation Spectroscopy (tICS) is an image correlation method 
where only the temporal autocorrelation of an image stack series is calculated, thus 
averaging the recorded dynamics over a given spatial area of the sample. This 
strategy can be assimilated to the parallel collection of several single-point FCS 
traces in different spatial locations, in order to maximize the signal-to-noise ratio of 
the measurement. tICS was used successfully to characterize the dynamics of 
several membrane proteins including integrins (160,161), wild-type cystic fibrosis 
transmembrane conductance regulator (CFTR) channel (162), and sodium-hydrogen 
exchange regulatory factor 1 (NHERF-1). In many cases, tICS results were 
confirmed by other diffusion measurements by alternative techniques such as FRAP 
or single particle tracking. 
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Starting from the generalized spatiotemporal correlation (Appendix A, Eq A.1), 
tICS is associated with an autocorrelation function of the form: 
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( ) ( )
















G , [4.1] 
where x,y are the spatial coordinates on the image plane (Eq. A.1).  
Experimentally, a temporal stack of images is collected and then the 
autocorrelation is calculated following Eq. 4.1 for each pixel of the stack. 
Meaningful tICS measurements require the frame rate to be appropriately matched 
to the time scale of the diffusion process under investigation. 
The analytical forms of ( )τ,0,0G  are rapidly calculated from general solutions 
of Eq. 4.1. For 3D free diffusion imaged by a Gaussian PSF, Eq. 4.1 reduces to 
(167) : 
 


























τ , [4.2] 
where S = σz/σxy is the ratio between the axial and the radial waists of the PSF and 









= . [4.3] 
Protein diffusion on membranes, however, is amenable to a 2D diffusion 
description, namely: 
 














τ . [4.4] 
Given our interest in processes occurring within the plasma membrane, further 
elaborations will concern only the 2D case. 
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When more than one molecular species are diffusing into the imaged area, the 
overall autocorrelation can be written as a sum of components expressed by Eq. 4.4, 
each one associated with a specific characteristic diffusion time τD,i : 
 















τ . [4.5] 
In eq. 4.5 ( )0,0,0iG  represents the amplitude of autocorrelation function due to the 
component i. ( )0,0,0iG  values are usually recovered as empirical parameters from 
actual autocorrelation measurements, because they are connected in a complex way 
to both the concentration and the intrinsic molecular brightness of the i-component. 
A very interesting condition occurs when the diffusing particle has very long 
(ideally infinite) characteristic diffusion time (immobile fraction). An “immobile” 
fraction may originate from an extended aggregation of the diffusing molecule 
triggered by some specific biochemical stimuli. For the simplest case of one 
diffusing moiety in presence of immobile fraction, Eq. 4.4 become: 
 














τ , [4.6] 
where the time offset ∞g  stems from the presence of the immobile component with 
∞→Dτ .  
Assuming constant molecular brightness, the fraction of immobile population Ximm 
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4.2 Average membrane diffusion properties of TRPV1  
In this section we shall describe the use of tICS to measure the average membrane 
diffusion of TRPV1 in the basal and activated states. 
 
4.2.1 Calibration of tICS technique 
Initially, the reliability of the tICS analysis protocol was put to the test. 
Fluorescent nanospheres of 40 nm were imaged in a water/glycerol solution of 
known viscosity (109 centipoises at 20°C) by using a CLSM. For each sample, 300 
images were sequentially acquired with a frame rate corresponding to Δτ = 65 ms 
between two consecutive images. ( )τ,0,0G  was calculated according to Eq. 4.1 and 
the diffusion coefficient D of the nanospheres was obtained by fitting ( )τ,0,0G  vs. τ 
to Eq. 4.2 (Fig. 4.2). The fitting yielded D=(4.4±0.1)*10-2 (# 10 experiments). Note 
that the radial resolution xyσ of the confocal microscope had been previously 
determined by analyzing the diffraction-limited image of fixed nanoparticles with 
100 nm diameter (§ 2.1.1). In excellent agreement with the recovered data, the 
Stokes-Einstein law yielded D=4.9*10-2 µm2/s for the adopted solution viscosity and 
temperature (Fig. 4.2), thus validating our tICS protocol. 
 
4.2.2 tICS on TRPV1 at basal state and under stimulation 
At first, only the receptor at basal state was investigated. tICS was applied to 
CHO cells transiently expressing TRPV1-YFP; YFP selection was motivated by its 
being the brightest variant among the available TRPV1-chimeras, thus ensuring the 
maximum S/N ratio. By exciting at 488 nm in a CLSM, we collected at maximum 
frame rate (Δτ=26 ms between two consecutive images, “fast acquisition” mode) 
300 sequential images of 10 µm x 10 µm membrane areas. The collection range was 
set to 500-600 nm. The excitation power was minimized to a level ensuring that 
little (<5%) if none photobleaching occurred over time (note that the presence of 
photobleaching is known to yield overestimated diffusion coefficients (167)).  
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Figure 4.2. tICS calibration. tICS curve obtained by imaging a dispersion of fluorescent 
microspheres (diameter=0.04 µm) in a mixture of water/glycerol (85% w/w). The 
measurement was performed using the same acquisition parameters used for living cells, 
namely λexc=488 nm, emission collected between 500-600 nm, and 65 ms frame rate (300 
frames). 
 
Fitting of tICS curves to Eq. 4.6 (Fig 4.3) showed rather fast loss of temporal 
correlation (τ=3.1±2.2 s), with an average diffusion coefficient Dfast= (7±2)*10-3 
µm2 (Tab. 4.1) (Fig. 4.3). This Dfast value is in agreement with the typical D values 
of transmembrane receptors (10-2-10-3 µm2/s) and about four orders of magnitude 
smaller than the D of cytosolic proteins (170). 
Although in “fast acquisition” mode no more than 300 images could be recorded,
( )τ,0,0G  was dissipated at the end of collection (7.8 s) by about 20% (Fig. 4.3). In 
order to reveal any additional slower diffusion component, we acquired for 600 s by 
using a longer time lag between frames (Δτ=2s, “slow acquisition” mode). In these 
conditions, ( )τ,0,0G  could be fitted to a sum of two exponential decays (Eq. 4.8) 
where the first component corresponded to the fast population (
fastD
τ ≈ 3 s) 
previously detected. 
 
































τ . [4.8] 
Importantly, the fit yielded g∞ ≈ 0, indicating that almost no immobile fraction of 
TRPV1-YFP exists at very long times. 
 
 
Figure 4.3. Representative autocorrelation function of membrane TRPV1-YFP acquired 
at Δt=26 ms (“fast” acquisition mode). Autocorrelation function is reported together with 
the relevant fit to a 2-dimension diffusion model. 
 
The slower TRPV1 population was associated with 
slowD
τ =370±189 s, yielding an 
average diffusion coefficient Dslow = (6±4)*10-5 µm2/s (Table 4.1). Thus, the two 
diffusive components were separated by about 2 orders of magnitude, although they 
displayed similar average autocorrelation amplitudes (Table 4.1). We should stress 
again that the amplitude values do not necessarily reflect the relative abundance of 
the two populations (§ 4.1.1). Only variations of their relative proportions would be 
indicative of concentration changes. 
The relevance of these results prompted us to verify whether the TRPV1 diffusion 
properties at basal state were independent from the protein expression levels. To do 
this, we subdivided the analyzed cells into three groups with different YFP emission 
intensities and calculated for each the average D value (Fig. 4.5). Our analysis 
highlighted that no statistical differences among diffusion coefficients were found at 
different expression levels. 




Figure 4.4. Representative autocorrelation function of membrane TRPV1-YFP acquired 
at Δt=2 s (“slow” acquisition mode).. (A) A representative autocorrelation function of 
membrane TRPV1-YFP is reported together with the relevant fit to a 2-dimension diffusion 
model. (B) Temporal trace of fluorescence intensity fluctuations showing negligible 
photobleaching. 
 
Starting from these findings on basal state of the receptor, we set out to 
investigate whether stimulation by RTX agonist (§ 3.2.1) could modulate the 
diffusion properties of TRPV1. Remarkably, agonist activation modified neither the 
presence of the two diffusing components, nor their respective diffusion 
coefficients. The relative correlation amplitudes, however, changed significantly as 
)0,0,0(slowG  became predominant (Tab. 4.1). The constancy of the diffusion 
coefficients suggested that the agonist induced little modification of the structural 
and/or oligomerization property of both TRPV1 components. Additionally, the 
fluorescence lifetime of TRPV1-YFP in the absence and in the presence of RTX 
remained unchanged (Tab. 4.1), indicating that the intrinsic brightness of the protein 
reporter did not affect the observed changes in autocorrelation amplitudes. These 
results indicated that the changes of autocorrelation amplitudes were produced by a 
concentration increase of slow-moving TRPV1. In this perspective, the slow TRPV1 
component identifies in part or totally with the functional receptor, i.e. the TRPV1 
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Table 4.1. Diffusion parameters derived from tICS measurements on membrane 
TRPV1-YFP and fluorescence lifetime of TRPV1-YFP. % AC: per cent of autocorrelation 
amplitude. D: diffusion coefficient. IF: Immobile fraction percentage. The %AC, D, and IF 
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0 20 2.99±0.09 
90±10 (5±3)*10-5 
a Note that the ratio between the autocorrelation amplitude (AC) of  fast and slow populations in 
nocodazole treatment cells (25%/40%) is the same of that calculate in basal condition (60%/40%) 
 
 
Figure 4.5. Diffusion coefficients vs. cellular expression levels. The histograms show the 
dependence of fast (A) and slow (B) diffusion coefficients upon protein expression level in 
living cells at basal condition. The results are divided in three sets of expression levels 
depending on fluorescence intensity values (a.u.): low expression level (from 50 to 150 a.u.), 
medium expression level (from 151 to 350 a.u.), and high expression level (from 351 to 550). 
Each column represents the statistical analysis of 4 cells (mean ± standard deviation).  
 
66    tICS: temporal dynamics of TRPV1 and TRPV1-microtubules complex on membrane 
 
 
4.3 Temporal dynamics of TRPV1-microtubule complex 
In section 4.2 we demonstrated that membrane TRPV1-YFP is characterized by at 
least two diffusing components with fairly different diffusion coefficients. The clear 
demonstration of TRPV1-microtubule interactions in living cells by FRET in 
Chapter 3 prompted us to clarify whether: 1) microtubule integrity affects the 
dynamic properties of the receptor at membrane level, 2) one or both components 
interact with microtubules. These issues are discussed in the following sections. 
4.3.1 Effect of microtubule disassembly on TRPV1 dynamics 
In order to verify the effect of microtubule integrity on TRPV1 dynamics, we 
carried out tICS experiments under cell treatment with nocodazole. Measurements 
were performed on CHO cells expressing TRPV1-YFP. Nocodazole treatment led to 
a 10-fold increase of diffusion coefficient values of both fast and slow subpools (p < 
0.0025, # = 30 cells). The ratio between the correlation amplitudes of the two 
populations was, however, virtually unaffected (Tab. 4.1). On the other hand, the 
mobility increase of TRPV1 was not correlated to non-specific cytoskeletal 
disruption effects. In fact, the addition of actin-disrupting cytochalasin D affected 
neither the diffusion coefficients nor the relative correlation amplitudes (Tab. 4.1). 
At odds with what observed in the presence of intact microtubules, autocorrelation 
curves showed large asymptotic offsets (~35%) upon nocodazole treatment. This 
effect was attributed to a significant level of immobile fraction, on account of the 
negligible photobleaching of YFP in our measurement conditions. Additionally, 
nocodazole was found to be non-influent on the intrinsic brightness of the YFP 
reporter, as witnessed by the constancy of the average fluorescence lifetime of 
TRPV1-YFP (Tab. 4.1). These findings suggest that integer microtubules are 
essential to maintain the physiological dynamic states of the receptor. 
4.3.2 Analysis of the dynamics of TRPV1-µT complex at basal state 
In order to identify whether one or both TRPV1 components interact with 
microtubules, tICS measurements were combined with FRET. tICS experiments 
were performed on cells in basal state expressing both TRPV1-E0GFP (donor) and 
TagRFP-αT (acceptor). Images in the donor (480-560 nm) and FRET (615-715 nm) 
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channels were acquired over time by selectively exciting the donor alone at 405 nm. 
We then calculated separate autocorrelation functions from the donor and FRET 
channels (Fig. 4.7). Analogously to previous experiments (§ 4.2), image temporal 
stacks were recorded in “fast” and “slow” acquisition modes, in order to recover fast 
and slow receptor dynamics. 
 
 
Figure 4.6 Representative autocorrelation function of membrane TRPV1-YFP upon 
nocodazole administration.  The image sequence was acquired at Δt=2 s. Autocorrelation 
function is reported together with the relevant fit to a biexponential 2D diffusion model. The 
offset calculated by fitting is 36%. 
 
The autocorrelation analysis of the donor channel was in complete agreement with 
those collected for TRPV1-YFP at basal state (Dfast = 5±1*10-3 µm2/s,  Dslow = 
9±5*10-5 µm2/s). This confirmed that YFP replacement by E0GFP had no effect on 
the mobility of the fusion construct, as expected by the close structural similarity of 
these fluorescent proteins. 
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Figure 4.7. tICS-FRET analysis. Autocorrelation function of intensity fluctuations collected 
in the donor channel (TRPV1-E0GFP, emission in the 480-560 nm range) and in the 
acceptor/FRET channel (TagRFP-αT, emission in the 615-715 nm range). Excitation was set 
to 405 nm. Left panels refer to “fast” acquisition mode, whereas right panels refer to “slow” 
acquisition mode. 
 
The autocorrelation curve of the FRET channel was nearly equivalent to TRPV1-
E0GFP in “slow acquisition” mode (Dslow = 4±9*10-5 µm2/s). On the other hand, 
when the fast acquisition mode was adopted, we observed no temporal dependence 
of autocorrelation in the FRET channel (Fig. 4.7). Control experiments on cells 
expressing TRPV1-E0GFP or TagRFP-αT alone (Fig. 4.8) confirmed that the 
observed pattern was associated only with the interaction between the receptor and 
microtubules. In cell expressing only the acceptor, the excitation at 405 nm led to 
null correlation when recording at >615 nm, in agreement with null absorption of 
TagRFP in the violet region of spectrum (§ 3.1.3, Fig. 3.3). The selection of the 
E0GFP/ TagRFP pair was indeed motivated by this photophysical feature, since it 
prevents mixing of acceptor dynamics with that of the complex. In cells expressing 
only the donor, a small amount of cross-talk intensity was visible in the FRET 
channel by exciting at 405 nm. Yet this signal was poorly autocorrelated, likely 
owing to the interference of detector noise (Fig. 4.8A). Accordingly, the signal 
Temporal dynamics of TRPV1-microtubule complex  69 
 
autocorrelation was present only for the fluorescence acquired in the donor channel 
(Fig. 4.8B).  
 
 
Figure 4.8. Control experiments on cell expressing TagRFP-αT or TRPV1-E0GFP. 
Upon excitation at 405 nm of cells expressing only TRPV1-E0GFP, we show the 
autocorrelation of the “cross-talk” signal collected in the emission interval λem=615-715 nm 
(A), and of the “donor” signal collected in the emission interval λem=480-560 nm (B). (C) 
Upon excitation at 405 nm of cells expressing only TagRFP-αT, we show the autocorrelation 
of the “bleed-through” signal collected in the emission interval λem =615-715 nm. Note that a 
positive correlation is present only in the donor emission channel, while cross-talk and bleed-
through signals are not correlated. Fit of the donor autocorrelation (red line in panel B) to a 
2D diffusion model yielded τD=140 s. 
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4.3.3 Analysis of the dynamics of TRPV1-microtubules complex upon 
agonist stimulation 
In section 4.2.2 we demonstrated that only the slow TRPV1 subpool is functional, 
i.e. sensitive to agonist stimulation. Later, (§ 4.3.2) we identified the slow TRPV1 
subpool with the microtubule-interacting component, and we stressed the relevance 
of microtubule integrity to maintain the physiological dynamic states of the 
receptor. These findings prompted us to investigate how receptor stimulation by 
RTX modulates the microtubule-TRPV1 dynamic interaction by using tICS-FRET. 
Much alike the basal state, only the slow diffusing component was found to interact 
with microtubules. Yet, tICS-FRET afforded Dslow =(3±3)*10-5 µm2/s. This value 
was statistically smaller (p=0.020) if compared to the diffusion coefficient of the 
donor or of the complex in absence of the agonist. This result indicated that agonist 
stimulation slowed the membrane diffusion of TRPV1-microtubule complex. 
 
 
Figure 4.9. tICS-FRET analysis on RTX-stimulated TRPV1-E0GFP. Autocorrelation 
function of intensity fluctuations collected in the donor channel (TRPV1-E0GFP, emission in 
the 480-560 nm range) and in the acceptor/FRET channel (TagRFP-αT, emission in the 615 -
715 nm range). Excitation was set to 405 nm. Left panels refer to “fast” acquisition mode, 
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4.4 Concluding remarks 
In conclusion, tICS and tICS-FRET measurements revealed that TRPV1 
membrane dynamics is characterized by at least two diffusing components (“fast” 
and “slow”) with fairly different mobilities. The “slow” component corresponds in 
part or on the whole to the functional form of the receptor and interacts in part or 
globally with integer microtubules. This pattern is not qualitatively modified by 
receptor activation by agonist RTX, although stimulation slows the membrane 
diffusion of TRPV1-microtubule complex. On the other hand, microtubule integrity 
is essential to maintain the physiological dynamic states of the receptor. These 
findings confirm that microtubule integrity preserves the functionality of the 
receptor, as also suggested in section 3.2.2.  
It is tempting to ascribe the lowered mobility of the slow TRPV1 component to its 
interaction with microtubules. Here, two non-exclusive situations can be envisaged: 
i) TRPV1 diffusion is slowed by reversible binding to microtubules, ii) TRPV1 is 
transiently confined in membrane regions and/or motion-guided by microtubules 
interaction. In chapter 6, we shall demonstrate that hypothesis ii) holds. 
Intriguingly, the “fast” TRPV1 subpool does not interact with microtubules and it 
is depleted upon agonist stimulation. On account of these evidences, we hypothesize 
that the “fast” component could include an immature form of the receptor. We shall 
demonstrate the validity of this hypothesis in the next chapter. 
 
4.5 Experimental Procedures 
4.5.1 Cell culture and transfections.    
In order to monitor the mebranne diffusion of TRPV1, CHO-K1 cells cultured 
onto 35-mm glass bottom were transfected with TRPV1-YFP plasmid, a kind gift 
from Wei Cheng (159) . The transfections were performed as described in §3.4.2 
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4.5.2 Temporal Image Correlation Spectroscopy (tICS) and tICS-FRET.  
tICS and tICS-FRET measurements were carried out with an Olympus FluoView 
1000-ASW-2.0 (Japan) confocal laser scanning microscope using a 63x (NA 1.4) 
planApo oil-immersion objective while setting the confocal pinhole at 1 Airy unit. 
For each measurement, a small section of the plasma membrane (about 13x13 µm2) 
was imaged (26 ms/frame or 2 s/frame) by acquiring 300 images. In conventional 
tICS on TRPV1- YFP, we excited at 488 nm and collected the emitted fluorescence 
in the 500-600 nm range. In tICS-FRET, we excited at 405 nm, we collected donor 
and emissions in the 480-560 and 615-715 nm range, respectively. Image 
autocorrelation was obtained by the ICS Temporal plugin of ImageJ; fitting of 
autocorrelation curves was performed by a custom-made software running on 
IgorPro 6 or Origin. 
4.5.3 Calibration of tICS technique  
For tICS calibration we used a dispersion of fluorescent microspheres 
(diameter=0.04 µm) in a mixture of water/glycerol (85% w/w). Measurements were 
performed with a confocal microscopy Olympus FluoView 1000-ASW-2.0 using 
the same acquisition parameters set for living cells, namely excitation at 488 nm, 
collection of fluorescence emission in the 500-600 nm range, and 65 ms frame rate 
(300 frames). Image autocorrelation was generated by the ICS Temporal plugin of 
ImageJ; fitting of autocorrelation curves was performed by a custom-made software 






Study of TRPV1 oligomerization in living cells: 
Homo-FRET imaging and Number and 
Brightness analysis 
In chapter 4 we demonstrated that membrane TRPV1 is subdivided in at least two 
components with fairly different diffusion properties. The slowest component 
corresponds to the functional form of the receptor, whereas the faster component 
could represent an immature form of TRPV1. The functional form, either in whole 
or in part, binds and is stabilized by integer microtubules. In fact, microtubule 
disassembly leads to strong changes in the dynamic properties of the receptor, 
including the formation of a significant immobile fraction, and consequently to the 
impairing of ion channel activity. These findings suggest the presence of structural 
variants of the receptor on the membrane, likely associated to different 
oligomerization degrees. In literature, however, oligomerization of the receptor was 
estimated only in vitro (79,171,172). In order to clarify this issue, this chapter 
reports our studies on the aggregation state of the receptor in living cells. In section 
5.1, by fluorescence anisotropy imaging (FAIM) associated to homo-FRET, we 
shall demonstrate that TRPV1 is already aggregated in basal condition and its 
oligomerization degree increases significantly upon microtubule disassembly. In 
section 5.2, by Number and Brightness (N&B) analysis, we shall investigate further 
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5.1 Fluorescence Anisotropy Imaging Microscopy (FAIM) on 
TRPV1 
5.1.1 Homo-FRET theory and FAIM 
At odds with more popular hetero-FRET (chapter 3), homo-FRET involves non-
radiative energy transfer between fluorophores of the same kind characterized by 
small Stokes’ shifts, to ensure adequate overlapping between absorption and 
emission spectra (173). Intensity ratios or lifetime measurements, however, can not 
be used for quantification of homo-FRET, because donor and acceptor are 
spectroscopically indistinguishable. The measurement of fluorescence 
depolarization upon non-radiative transfer, albeit just one of many ways to quantify 
hetero-FRET, is the most established method of detecting homo-FRET (174).  
From a photophysical point of view, excitation of any fluorescent moiety with 
polarized light results in photoselection of fluorophores sharing a component of 
their absorption transition dipole moment with the polarization direction of the 
excitation light. Fluorescence emission, however, is partially depolarized with 
respect to excitation, owing to probe rotation occurring during the life of the excited 
state. The degree of depolarization is measured by resolving ||I  and ⊥I  relative to 
the polarization of the excitation light. The concept of fluorescence anisotropy 
imaging microscopy (FAIM) is to measure the polarization orientation of the 
fluorescence relative to that of the excitation light in every image pixel. The 












|| , [5.1] 
where ||I  and ⊥I  are the fluorescence intensities with parallel and perpendicular 
polarizations with respect to excitation, and G is the calibration factor that accounts 
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for polarization effects of the collection optics. Fig. 5.1 illustrates the essential 
features of FAIM. 
 
 
Figure 5.1. Fluorescence anisotropy imaging microscopy. Fluorescence-labeled molecules 
in a sample are excited with linearly polarized light (Iex). The amount of depolarization that 
has occurred during the lifetime of the fluorophore is measured by resolving the fluorescence 
intensity parallel and perpendicular to the excitation polarization (I║ and I┴ ). Images of I║ and 
I┴ yield pixel-by-pixel anisotropy measurements, resolving molecular features related to 
polarization such as molecular rotation. (Adapted from (175)) 
 
Fluorescence depolarization is mainly due to rotational diffusion and FRET 
between molecules of different orientation (175). When molecular rotation is 
hindered, FRET is the main channel of depolarization. Fig. 5.2 depicts a classical 
context for homo-FRET measurements: a receptor membrane dimer is linked to two 
FPs whose transition dipoles are randomly oriented. Homo-FRET leads to 
depolarized emission, since the energy transfer does not maintain the polarization of 
the excitation light. Additionally, because the same fluorophore acts both as donor 
and acceptor, the transfer of energy is reversible, increasing the extent of 
depolarization (175). This “bouncing” excitation leads to a significant difference 
between the anisotropy of the reporter with a monomeric (rmono) or a multimeric (ret) 
receptor (175). 
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Figure 5.2. Schematic representation of homo-FRET in a dimer of GFP anchored to a 
membrane. Adapted from (176) 
 
The loss of polarization upon homo-FRET affords an opportunity for cluster-size 
quantification. Indeed, the maximum amount of homo-FRET depolarization for a 
defined cluster occurs when the energy transfer has reached equilibrium, that is, a 
point where all molecules in the cluster have an equal probability of emitting a 
photon. Runnels and Scarlata (173) derived a set of equations to predict the amount 
of depolarization based on cluster size and inter-fluorophore distance within the 





















FrrN , [5.2] 
where Nr the emission anisotropy for a single cluster, 1r   is the emission 
anisotropy for the initially excited molecule (or a monomer), etr  is the average 
anisotropy of fluorophores that are indirectly excited after homo-FRET (limiting 
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anisotropy), τ represent the average lifetime of the fluorophore, N is the number of 
fluorophores in the cluster, and F is Förster’s transfer rate (§3.1.1, Eq. 3.1). For 
randomly oriented fluorophores, the limiting anisotropy approaches zero since 
016.0=etr  (173). 
In homo-FRET studies the depolarization due to intrinsic rotational motion of 
fluorophore must be negligible (175). Apart from viscous intracellular regions such 
as the membrane, this condition can be simply accommodated for by using a 
fluorescent probe for which the characteristic rotation time Θ of the molecule is 
much larger than its lifetime. FPs share this property, as they display lifetimes in the 
1-3 ns range and Θ >20 ns at the very low viscosity of aqueous environment. (177). 
 
5.1.2  FAIM measurements on basal and stimulated TRPV1 
As benchmark, we carried out homo-FRET / FAIM on proteins with a known 
state of oligomerization: monomeric YFP and EGFP, and a EGFP tetrameric 
chimera. All these proteins were excited at the same wavelength (488 nm) and 
imaged as freely-diffusing molecules in the cytoplasm of CHO cells. We found out 
<r>=0.30±0.03 and <r>=0.27±0.02 for monomeric EGFP and YFP, respectively, 
in good agreement with literature data (178). Conversely, tetrameric EGFP showed 
<r>=0.19±0.04, clearly indicating the presence of active homo-FRET. 
Next, we carried out FAIM measurements on basal and RTX-activated TRPV1-
YFP expressed on the plasma membrane of CHO cells (Fig. 5.4). YFP reporter was 
chosen on account of its small Stokes’ shift that increases the Forster radius 
(R0=5.11 nm (179)) and therefore the efficiency of homo-FRET.  
Interestingly, we found out that basal TRPV1-YFP is associated with a 
significantly smaller <r> with respect to monomeric YFP (Tab. 5.1), at odds with 
its hampered mobility due to membrane localization. The decrease of <r> can not be 
attributed to changes in the photophysics of emission, since YFP retains the same 
lifetime as free protein or conjugated to TRPV1 (Tab. 5.1). These data 
unequivocally demonstrate that the observed reduction in anisotropy due to homo-
FRET among YFP reporters, thus indicating the aggregated form of the receptor at 
basal state. Agonist stimulation by RTX changed significantly neither the <r> 
value, nor the YFP lifetime (Tab. 5.1). 
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Figure 5.3. Anisotropy measurements on cells transfected with YFP, EGFP and 
EGFPx4. The intensity and anisotropy intracellular maps of YFP (upper panels), EGFP 
monomer (middle panels), and EGFP tetramer (lower panels) are shown. 
 
Table 5.1. Average anisotropy and lifetime value of YFP and TRPV1-YFP at basal 
condition and upon administration of different drugs. 
 <r> <τ> #  cells 
YFP 0.27±0.02 3.00±0.05 20 
TRPV1-YFP 0.18±0.03 3.08±0.04 15 
TRPV1-YFP + RTX 0.18±0.04 2.99±0.09 15 
TRPV1 + Nocodazole 0.12±0.03 2.99±0.08 40 
TRPV1 + Cytochalasin D 0.17±0.02 - 20 
 
A semi-quantitative estimate of the aggregation state at basal and under agonist 
stimulation can be obtained by applying Eq. 5.2. The Förster’s homo-transfer rate F 
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of YFP was calculated by Eq. 3.1 (§ 3.1.1) assuming inter-reporter distances from 4 
to 10 nm. Then, the F values were used to determine Nr  by setting r1=0.27 
(monomer YFP), ret=0 (random orientation of homo-FRET acceptors), and τ=3 
(YFP) ns in Eq. 5.2. Results are reported in Tab. 5.2. Experimental <r> values were 
consistent for dimers and/or tetramers under the assumption of YFP-YFP distances 
of 5-7 nm between dipoles. Larger distances would imply further clusterization of 
the receptor in physiological state. It should be reminded that TRPV1 was shown to 
adopt a tetrameric configuration in vitro with inter-subunit distance around 10 nm (§ 
1.2) (79). Such a value is in keeping with a YFP-YFP distance of 5-7 nm if the size 
of 2 YFPs are taken into account. 
 
Figure 5.4. Fluorescence intensity and anisotropy images of cells expressing TRPV1-
YFP at basal condition and upon RTX stimulation. 
 
5.1.3  FAIM measurements on TRPV1 under microtubule disassembly 
In chapter 4 we highlighted by tICS that microtubule disassembly produces a 
significant level of immobile receptor fraction (35% of the global autocorrelation 
amplitude). In order to investigate possible changes in TRPV1 oligomerization, we 
carried out FAIM experiments in cells treated with nocodazole. 
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Remarkably, microtubule disassembly led to <r>=0.13±0.03 without altering the 
YFP lifetime (Table 5.1). This strong reduction in anisotropy with respect to the 
basal state suggested an increase in homo-FRET triggered by a larger 
oligomerization degree of the receptor. Assuming that only a fraction of TRPV1 
extensively aggregates, as advocated by the immobile pool in tICS measurements, 
Tab. 5.2 shows that large complexes of tens of TRPV1 units may make up for the 
observed reduction in average anisotropy.  
On the other hand, the administration of actin-depolymerizing cytochalasin-D 
instead of nocodazole did not lead to an immobile TRPV1 fraction in tICS 
measurements (§ 4.3.1) and, coherently, had no effect on <r> in FAIM experiments 
(Fig. 5.5, Tab. 5.1). These findings indicate that microtubule disassembly and the 
loss of microtubule-TRPV1 interaction leads to extensive receptor aggregation. It is 
tempting to attribute the observed loss of TRPV1 functionality upon microtubule 
disassembly to the non-physiological oligomerization state of the receptor. 
 
Figure 5.5. Fluorescence intensity and anisotropy images of cells expressing TRPV1-
YFP upon nocodazole or cytochalasin D tretment.  
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Table 5.2 Expected anisotropy value depending on fluorophore distances and number of 
fluorophores for each cluster. The anisotropy values are calculated following the equation 
5.2. 




4 5 6 7 8 9 10 
1 0.27 0.27 0.27 0.27 0.27 0.27 0.27 
2 0.15 0.18 0.21 0.24 0.25 0.26 0.27 
4 0.08 0.10 0.15 0.19 0.23 0.25 0.26 
10 0.03 0.05 0.08 0.12 0.17 0.21 0.23 
20 0.02 0.02 0.04 0.08 0.12 0.17 0.20 
 
 
5.2 The Number and Brightness analysis 
5.2.1. Photophysical background of N&B analysis 
Number and Brightness (N&B) is an imaging method based on moment analysis 
of fluorescence fluctuations. N&B is particularly suitable for the detection and 
quantification of protein aggregation states (180-182) . 
In N&B analysis, the average intensity k  and variance 2σ  of a given pixel are 
















2σ , [5.4] 
where ki is the pixel intensity collected for the image i (0 ≤ i ≤ K). Now, let ε  be the 
molecular brightness of the fluorescent particle under observation. ε  is defined as 
the number of photons emitted per second per particle when the particle is at the 
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center of the illumination volume (183). Thus, ε  reflects the aggregation state of 
emitting particles.  
If n is the average number of particles in the illumination volume, the average 
intensity is given by: 
 
 0knSk += ε , [5.5] 
where k0 is the intensity offset and S is the conversion factor between one photon 
detected and the number of digital levels (DLs) produced by the detector electronics. 
For a photon-counting detector, S=1 and k0=0 
The variance 2σ  is composed by two contributions (183), according to:  
 
 222 dn σσσ += . [5.6] 
Here, 2nσ  is the variance of fluctuations due to changes in the number of molecules 
(and/or brightness flickering). The dependence of 2nσ  from molecular number and 
brightness is easily understood by considering two pixels characterized by the same 
average intensity k  but different values of n and ε: the variance will be higher at 
the pixel were few bright particles are moving compared to the other pixel at which 
many dim particles are diffusing (Fig. 5.6). Fluctuation theory based on Poissonian 
statistics (183) predicts that 2nσ  is given by: 
 
 nSn
222 εσ = . [5.7] 
2
dσ  is the variance attributable to the count statistics or shot noise of the detector, 
which is expressed by (183):  
 
 20
22 σεσ += nSd . [5.8] 
Here, 20σ  is the read-out noise of the detector (i.e. the intensity variance measured 
when zero fluorescence is collected). For a photon-counting detector, 020 =σ . 
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Next, the N and B parameters are defined following the treatment of Digman et al. 
(183). B is the apparent brightness of the fluorescent species and it is obtained for 
each pixel as the reciprocal of the ratio between the average fluorescence intensity 
















Figure 5.6. Schematic description of intensity and variance of a fluorescence signal over 
time. At pixels k (A) and j (B) the average intensity is the same but the standard deviation is 
much larger at pixel k than at pixel j. This is due to few bright particles fluctuating at pixel k 
while at pixel j there are a large number of dim particles. Panels C and D show schematically 
the histogram of counts corresponding to the situation in panels A and B, respectively. 
(Adapted from (183)) 
 
By using Eq. 5.5-5.9, B can be expressed as function of the molecular brightness: 
 
 ( )1+= εSB . [5.10] 
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B is particularly useful to identify the parts of the image that contain immobile 




2 kkd −==− σσσ  and B=1. Conversely, pixels that contain mobile particles 
show B>1. The oligomerization degree M of a mobile multimeric fluorescent 
species can be easily calculated from the B value and that of the monomeric species 









BM . [5.11] 
For a multimeric protein labeled with a FP reporter, Bmon is usually determined by 
looking at a reference monomeric FP chimera in the same experimental conditions 
(laser power and integration time in each pixel) adopted to image the target protein. 
For pixels containing a mixture of mobile and immobile components the value of B 
will be intermediate between 1 and that of the mobile fraction: 
 
 )1( mobmobmob fBfB ++= , [5.12] 
where mobB  is the apparent brightness of the mobile fraction and mobf  is its 









N is defined as the ratio between the average intensity and B, and it represents the 
apparent number of emitting particles. It is easy to demonstrate that N depends only 




















N&B analysis involves mapping each pixel of the image stack in a plot of B vs. N 
from which the presence of immobile fraction and the oligomerization degree of the 
species under observation can be determined after a suitable calibration. In a 
meaningful N&B measurement, the pixel dwell time should always be small enough 
to ensure the recording of fluorescence fluctuations (183). On the other hand, the 
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frame time must be larger than the characteristic diffusion time to ensure that pixel 
occupation is governed by Poissonian statistics and Eq. 5.7 holds (183). 
Since the error in the determination of the average and the variance decreases as 
the square-root of the number of independent measurements, the accuracy of N&B 
analysis increases as more frames are collected. Typically 10-20 frames are 
necessary to determine the brightness and number of particles and to be capable of 
showing the location of molecular aggregates. Spurious phenomena such as 
photobleaching or cell motion, which would increase the recorded variance, can be 
removed by suitable algorithms based on high-pass filters (183). Nonetheless, this 
procedure works only if the intensity changes due to cell movement or 
photobleaching are slower than particle fluctuations. 
5.2.2 N&B analysis for quantitative investigation of oligomerization status of 
TRPV1 before and after activation 
In section 5.1 we demonstrated that TRPV1 oligomerizes in both basal and 
agonist-activated states. Accordingly, N&B was applied to characterize further the 
oligomerization degree of TRPV1 on the cell membrane. N&B experiments were 
carried out in the confocal apparatus by collecting 100 sequential images. Pixel 
dwell time and frame time were set to 20 µs and 1.6 s, respectively. We should note 
that only the fast-moving TRPV1 subpools could be fully observed as mobile 
fraction under the adopted frame-time. The slow-moving TRPV1 fraction largely 
behaved as “immobile fraction” in the experimental conditions of the N&B 
experiments (characteristic diffusion time τ=370±189 s vs. frame time of 1.6 s), 
yielding B=1. A frame time matching the mobility of the slow-moving subpool was 
not accessible on account of by significant cell movement and extensive 
photobleaching during the measurements.  
In order to relate the molecular brightness to the oligomerization degree, we first 
observed a monomeric FP benchmark that diffuses within the membrane. The 
choice fell on the fusion construct farnesyl-EGFP (EGFP-F), on account of its 
membrane arrangement similar to TRPV1-FP (185). In fact, EGFP-F intrudes the 
farnesyl lipid tail into the membrane bilayer and exposes the FP reporter on the 
cytoplasmic side. As expected, N&B revealed a homogeneous distribution of 
monomeric farnesyl-EGFP on the membrane (Fig. 5.7A-B). Upon excitation at 488 
nm, the analysis afforded B = 1.13 ± 0.03 counts/molecule (number of cells = 8), 
corresponding to an average ε = 0.13 ± 0.03 counts/molecule (Fig. 5.7C). Under the 
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same excitation/emission conditions we found out that monomeric EGFP and YFP 
were characterized by the same brightness (Fig. 5.8). This can be easily explained 
by considering that YFP is brighter than EGFP when both proteins are excited at 
their absorption maxima (YFP: 525 nm, EGFP: 488 nm, see Fig. 3.3, § 3.1.3), but 
this difference becomes negligible when 488 nm excitation is adopted, because of 
the lower absorption of YFP at this wavelength. Thus, farnesyl-EGFP represented a 
useful benchmark of TRPV1-YFP, too. 
 
 
Fig. 5.7. N&B analysis of farnesyl-EGFP. (A) Confocal fluorescence image of a CHO cell 
transiently transfected with farnesyl-EGFP (EGFP-F) (scale bar: 10µm). Dwell time is set to 
20 µs/pixel. (B) For the same cell shown in (A), selection of the pixels with apparent 
brightness corresponding to monomers (B=1.13 cpm) (ε=0.13 cpm=molecular brightness): 
monomers are distributed uniformly throughout the cell. (C) Brightness histogram: a 
Gaussian distribution centered at B=1.13 cpm identifies the monomer; only a few pixels are 
outside the distribution of the monomeric brightness. 
 
N&B measurements on TRPV1-YFP yielded B = 1.26 ± 0.10 [# 10cells] (Fig. 
5.9A-C), although a significant number of pixels localized near B = 1. B = 1.26 
corresponds to ε = 0.26 ± 0.02 counts/molecule, a value which is twice as that 
observed for the monomeric benchmark. 
 
The Number and Brightness analysis  87 
 
 
Fig. 5.8. Determination of the molecular brightness of YFP and GFP by N&B analysis. 
(A) Confocal fluorescence image of a CHO-K1 cell transiently transfected with YFP (scale 
bar: 10µm). Dwell time is set to 12.5 µs/pixel;. (B) For the same cell shown in (A), selection 
of pixels whose brightness corresponds to a YFP monomer, B=1.13 cpm. Notably, monomers 
are distributed uniformly throughout the cell. (C) Brightness histogram. A Gaussian 
distribution centered at B=1.13 cpm identifies the monomeric protein. Only a few pixels are 
outside the distribution of the monomeric brightness. (D-F) N&B analysis is performed on a 
cell transiently transfected with GFP (scale bar: 10µm) and imaged with the same 
experimental settings described above. The analysis reveals a homogeneous distribution of 
the monomeric form of GFP throughout the cell, with an average brightness of 1.14 cpm. (G) 
Cumulative results. In our N&B setup the ratio of molecular brightness (ε=B-1) between YFP 
and GFP is approximately 1. Thus EGFP-F and TRPV1-YFP can be directly compared in 
terms of oligomerization state as obtained from N&B analysis.  
 
N&B analysis was also performed upon agonist (RTX) stimulation. With respect 
to basal state, both the “immobile” fraction with B=1 (blue) and the region with B 
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=1.52 (red), corresponding to tetrameric receptor arrangement, became more 
populated in the B/intensity map (Fig. 5.9D-F).  
 
 
Fig 5.9. N&B analysis of TRPV1 oligomerization state. (A) Confocal fluorescence image 
of a CHO-K1 cell transiently transfected with TRPV1-YFP at basal state (scale bar: 10µm). 
(B) Pixels of corresponding to B=1 (“slow” diffusing component that behaves as immobile 
fraction in the frame time adopted for N&B analysis, see text) and B=1.52 (tetramers) were 
colored in blue and red, respectively. (C) B vs. intensity plot reveals that most pixels have 
average apparent brightness of 1.26 cpm (ε=0.26 cpm), corresponding to dimers. The blue 
and red rectangles enclose pixels corresponding to B=1 and B=1.52, respectively. (D) 
Confocal fluorescence image of the same cell of (A) after stimulation with RTX. (E) 
Similarly to (B), pixels of corresponding to B=1 and B=1.52 (tetramers) were colored in blue 
and red, respectively. (F) Brightness-vs. intensity plot shows a significant increase of B=1 
pixels (blue rectangle) relevant to the slow TRPV1 component. 
 
These findings were fully accounted for by the population increase of slow-
moving, functional receptor upon agonist stimulation that was already observed by 
tICS (§ 4.2.2). Although the slow-moving TRPV1 subpool was observed prevalently 
as immobile fraction (B=1), some molecules diffused in times matching the 
acquisition frame time, and were visualized as tetramers with B = 1.52 consistently 
with the tetrameric arrangement reported in literature for functional TRPV1. 
Concerning the fast-moving TRPV1 subpool, two possible oligomerization states 
could be envisaged by N&B data. We might assign B=1.26 to dimers only, under the 
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assumption that pixels characterized by this B value contains only the fast-moving 
TRPV1. On the other hand, if pixels contain both populations, we might consider 
B=1.26 as the intensity-weighted average between B=1 (blue rectangle in Fig. 5.9C) 
and B=1.52 (red rectangle in Fig. 5.9C). As discussed before, B=1 should be 
assigned to the slow component since its diffusion can not be visualized as 
fluctuation in our frame time. The value B=1.52 would imply a tetrameric 
oligomerization for the fast diffusing component. We can not exclude the presence 
of intermediate cases (i.e. mixtures of dimers and tetramers), under the reasonable 
assumption of receptor aggregation/disaggregation processes at equilibrium. 
 
 
Fig. 5.10. N&B analyses of TRPV1-YFP oligomerization state after cytochalasin D. (A) 
Confocal fluorescence image of a CHO cell transiently expressing TRPV1-YFP at basal state 
(scale bar: 10µm). (B) N&B analysis reveals a homogeneous distribution of B=1.26 pixels 
throughout the cell of panel (A). (C) Brightness histogram where a Gaussian distribution 
centered at 1.26 cpm is denoted by a red line. Notably, only a few pixels are outside the 
distribution. (D) Confocal fluorescence image of the same CHO cell of (A) after stimulation 
with Cytochalasin D. (F) Same as in panel (C).  
Finally, we measured N&B in presence of nocodazole and cytochalasin to test the 
effect of cytoskeletal disruption on TRPV1 oligomerization. Cytochalasin 
administration led to B=1.26 identical to resting cells (Fig 5.10), in full consistency 
with the absence of interactions between TRPV1 and the actin cytoskeleton. 
Unfortunately, nocodazole treatment led to extensive bleaching of the fluorescence, 
thus preventing N&B analysis. This finding is in agreement with FAIM and tICS 
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data indicating that microtubule disassembly leads to the formation of large and 
immobile TRPV1 oligomers prone to photobleaching (Fig. 5.11). 
 
 
Fig.5.11 Fluorescence intensity analysis of cells expressing TRPV1-YFP after nocodazole 
treatment. First (A) and last (B) intensity image of a time stack relevant to TRPV1-YFP after 
after nocodazole treatment. (C) The intensity vs. time plot shows a strong photobleaching 
occurring during the measurement. 
 
 
5.3 Concluding remarks 
In conclusion, by fluorescence anisotropy imaging (FAIM) associated to homo-
FRET we demonstrated that TRPV1 is aggregated in basal condition and its 
oligomerization degree increases significantly upon microtubule disassembly. The 
extensive aggregation might explain the loss of TRPV1 functionality upon 
microtubule disassembly observed at Chapter 3. On the other hand, actin 
depolymerization did not produce changes in the aggregation state of TRPV1, 
highlighting the specific role of microtubule in stabilizing the receptor in its 
functional state. The tetrameric structure of the functional receptor was compatible 
with our Number and Brightness (N&B) results. N&B also witnessed the 
concentration increase of the functional, slow-moving TRPV1 subpool upon agonist 
stimulation. Two limiting oligomerization states are compatible with N&B data for 
the fast-moving TRPV1 subpool: 1) dimeric, under the assumption of spatial 
segregation with respect to the slow-moving subpool, or 2) tetrameric, otherwise. 
Intermediate cases, i.e. dimers and tetramers interconverting at equilibrium, are 
nonetheless possible.  
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5.4 Experimental procedures 
5.4.1 Plasmids, cell culture and trasfections 
For this set of experiments we used the plasmid TRPV1-YFP (described in 
§3.4.1). EGFP and EYFP plasmids (from Clontech) were used to calibrate the 
anisotropy value of monomer in FAIM and the brightness ratio in N&B analysis. 
The plasmid encoding for farnesyl-EGFP is a kind gift of Dr. Tarik F. Haydar, 
Laboratory of Neural Development and Intellectual Disorders, Boston University. 
CHO-K1 cells from ATCC (CCL-61 ATCC) were cultured and transfected as 
described in §3.4.2 
5.4.2 FAIM: Anisotropy imaging.  
Measurements were carried out by a Leica TCS SP2 inverted confocal microscope 
(Leica Microsystems AG, Wetzlar, Germany). 40x (NA 1.25) planApo oil 
immersion objectives were used while setting the confocal pinhole at 1 Airy unit. 
For anisotropy imaging on TRPV1-YFP, samples were excited at 488 nm and 
fluorescence was collected in the 520-600 nm range at parallel and perpendicular 
polarization with respect to the exciting beam by using the internal polarizer of the 
microscope. Anisotropy maps were obtained by a custom-made plugin running 
under ImageJ. Images were smoothed with a Gaussian filter with a standard 
deviation of 1 pixel. When processing data acquired from cells, the images were 
corrected by subtracting the average background intensity measured from a small 
region in the image where no cells were visible. 
5.4.3 Number and Brightness (N&B) analysis.  
We set the Olympus FluoView 1000 to the pseudo-photon-counting data 
acquisition mode. In this mode, the parameters needed for N&B analysis are the 
detector offset, the factor S that converts photon counts to digital levels, and the 
readout variance σ02. For the present analysis these parameters were estimated 
according to (184). We obtained S=3.5, σ02=0, and offset=0. 256x256 images at 8 
bits were collected with a pixel dwell time of 20µs. A time series of 100 frames with 
no programmed delay between images was used to reduce statistical error. Low 
laser power was used to avoid photobleaching. The N&B analysis was performed 
using the SimFCS software (www.lfd.uci.edu). In order to calibrate laser power and 
scanning conditions required for the measurement of a monomeric protein diffusing 
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within membranes, we measured the brightness of CHO-K1 cells transiently 
expressing the nonaggregating farnesyl-EGFP adduct (EGFP-F). These conditions 
were then used for the TRPV1-YFP experiments. We separately measured the 
difference in apparent brightness (B) between EGFP and YFP by using CHO-K1 
cells transiently expressing the two untagged variants (Fig. S2): we found a 









Spatio-Temporal Image Correlation 
Spectroscopy: revealing connections between 
TRPV1 function and receptor organization on 
membrane  
In Chapter 3 we showed by FRET that TRPV1 interacts with caveolin-1 and 
tubulin dimers belonging to integer microtubules as a way to de-sensitize and 
stabilize the activated receptor, respectively. In Chapter 4 we demonstrated by 
temporal Image Correlation Spectroscopy (tICS) that membrane TRPV1 entails at 
least two components. The slowest component corresponds to the functional 
receptor and, in part or totally, was found to interact with intact microtubules. We 
can not exclude, however, that one or both components could be subdivided in 
further subpools characterized by different types of diffusion processes. The 
comprehensive picture of TRPV1 diffusion/binding processes and its spatial 
organization on the membrane can be clarified only by image correlation protocols 
that consider both the spatial and temporal coordinates. Accordingly, we availed 
ourselves of a new fluorescence fluctuation approach named iMSD analysis. iMSD 
is based on Spatio-Temporal Correlation Spectroscopy (STICS) and its 
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photophysical background will be presented in section 6.1. In Section 6.2 we shall 
demonstrate that iMSD can be proficiently combined with FRET to highlight the 
relationship between diffusion and spatial organization of the interacting/non-
interacting receptor subpools. In particular, we shall demonstrate that TRPV1 
complexes with caveolin-1 and tubulin are spatially-decoupled and follow distinct 
diffusion processes. A further non-interacting TRPV1 subpool will be assigned to an 
immature form of the receptor that plays the role of membrane reservoir.  
 
 
6.1 iMSD approach to spatio-temporal image correlation 
spectroscopy 
Spatio-Temporal Correlation Spectroscopy (STICS) is a fluorescence fluctuation 
technique that identifies the kind of spatial movements of fluorescently labeled 
adhesion macromolecules within the plasma membrane of living cells (168) (161). 
In contrast with tICS, STICS relies on a complete calculation of both the temporal 
and all-spatial correlation lags for intensity fluctuations from an image stack. 
Recently a group in our lab has proposed a modified STICS approach that is suitable 
for determining diffusion laws of biomolecules in live cells with high temporal and 
spatial resolution and no need for the preliminary assumption of a specific 
interpretative model. The novel STICS approach was named iMSD analysis (186). 
Recent data demonstrated that iMSD is particularly suitable to study protein 
membrane dynamics on wide spatial and temporal scales, thus fully complementing 
high-speed single-molecule techniques in the investigation of membrane dynamics 
at the nanoscale (187). 
6.1.1 Photophysical background of iMSD  
In Appendix A we showed that the image spatiotemporal autocorrelation function 
G(ξ,χ,τ) is calculated from a temporal stack of images according to: 
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where I(x,y,t) stands for the fluorescence intensity of the pixel located in the (x,y) 
position of the image at time t, and ξ, χ, τ  represent variable spatial and temporal 
increments. Given the usual z-axial symmetry of the Gaussian illumination beam, it 
is useful to recast the ξ and χ spatial-lags into a single parameter (Appendix A): 
 
 . [6.2] 
The spatiotemporal correlation function in a 2D space (membrane bilayer) is 
reported as Eq. A.11 of Appendix A. This equation can be rewritten in an equivalent 
(but more informative) form: 
 
 ( ) ( ) ( )ττρτρ Φ⋅⋅= ggGG CD ,)0,0(,2 , [6.3] 
where gC and gΦ are the autocorrelation components due to molecular motion and 
brightness flickering, respectively. The gC component is expressed by: 
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Cg , [6.4] 
with 
 
 . [6.5] 
D is the diffusion coefficient, α takes into account the nature of the diffusive 
process (α =1: isotropic diffusion, α <1 confined diffusion, α >1 guided diffusion), 
and σ0 is a parameter related to the size of the diffusing moiety (186). Indeed, it can 
be demonstrated that the diameter d of a diffusing particle can be approximated by: 
 
 , [6.6] 
where σxy is the spatial resolution of the microscope on the focal plane (§ 2.1.1). 
 is denoted as iMSD, since it is conceptually and mathematically analogous to 
the mean square displacement (MSD) of single particle tracking analysis (186).  
The gΦ component is expressed by: 
222 χξρ +=
( ) 202 4 σττσ α += Dr
22
0 xyd σσ −=
2
rσ
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τρ exp,g , [6.7] 
where τΦ is the characteristic time of brightness flickering. Several photophysical 
and photochemical processes result in brightness flickering. The most relevant ones 
are quenching and FRET upon biomolecular binding. When binding is involved, τΦ 
corresponds the characteristic time of reversible association/dissociation of the 
complex, τΒ. 
Two limit cases are of particular relevance for iMSD analysis: 1) constant 
brightness and 2) diffusion time much slower than the characteristic time of 
brightness flickering. In case (1), only molecular diffusion contributes to the 
recorded autocorrelation function, that is: 
 
 ( ) ( )τρτρ ,)0,0(,2 CD gGG ⋅= . [6.8] 
Experimental data can be fitted to Eqs. 6.4-6.5 and 6.8 to recover diffusion 
parameters. An alternative way to analyze molecular diffusion is provided by 
inspecting the time derivative of ( )τρ,2DG : 
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At time  when: 
 
 , [6.10] 
the time-derivative in Eq. 6.11 goes to zero. It is easy to demonstrate that  
corresponds to a maximum of ( )τρ,2DG  vs. τ at constant ρ.  
By inserting (6.5) into (6.10), for a given , we have:  
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We can recover the relevant diffusion parameters directly from the plot of vs. 
by using Eq. 6.11. For isotropic diffusion (α = 1), we have a linear 
dependence of  from ατmax , whereas super- and sub-diffusion processes (α≠1) 
are characterized by non-linear plots.  
In case (2), i.e. when the particle diffusion time is much slower with respect to its 
brightness flickering, we can assume D ≈ 0. Thus, Eq. 6.3 becomes: 
 



























2 GG D . [6.12] 
In this condition, Eq. 6.12 indicates that, ( )τρ,2DG  is expressed by a Gaussian 
function of constant width and time-decreasing amplitude. 
6.1.2 iMSD to study mixed binding and diffusion 
An analytical form of G2D(ρ,τ) is not available for a heterogeneous biological 
context containing different types of diffusing particles. An empirical approach 
considers a total autocorrelation function given by a sum of individual components, 
such as: 
 
 , [6.13] 
where Ai is the correlation amplitude of the ith component at zero space and time, 
and gi(ρ,τ) represents its relevant autocorrelation function. The presence of a known 
binding equilibrium entailing a single component, however, helps to simplify the 
analysis. Indeed, in such a case we can use a “FRET filter”, as already demonstrated 
for tICS (§ 4.3). The FRET filter is obtained by labeling the target molecule and its 
binding partner by a suitable FRET couple. Notably, the sensitized FRET signal 
associated with a molecular complex, or the concomitant donor quenching, depend 
directly on the reversible formation/dissociation of the complex itself. This leads to 
brightness flickering, which is in turn reflected into the general autocorrelation 
function by means of the characteristic binding time τB. Accordingly, it is useful to 
define a “FRET” correlation function that accounts for both diffusion and binding 
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 . [6.14] 
iMSD-FRET approach is based on Eq. 6.14. In Section 6.2 we shall apply iMSD-
FRET to recover the intrinsic diffusion properties of the TRPV1-caveolin-1 
(TRPV1-C) and TRPV1-tubulin (TRPV1-T) complexes.  
 
 
6.2 Spatio-temporal investigation of TRPV1 membrane 
mobility by iMSD 
6.2.1 Spatiotemporal organization of TRPV1-caveolin (TRPV1-C) complex 
 The diffusion characteristics of the TRPV1-caveolin-1 complex (TRPV1-C) were 
analyzed by FRET-iMSD in TIRF modality. Experimentally, CHO cells were 
imaged every 10 ms up to 60s. A time-dependent spatial correlation function 
GFRET(ρ,τ) was calculated from each image collected in the FRET acceptor channel 
of RFP emission. GFRET(ρ,τ) was fitted to Eq. 6.5-6.14 to take into account both 
diffusion and FRET flickering for TRPV1-C. Notably, the profile of iMSD (Eq. 6.5) 
due to TRPV1-C was nearly time-independent after a fast transient of small 
amplitude (Fig. 6.1A). This finding demonstrates that TRPV1 and caveolin-1 do not 
co-diffuse significantly as a complex. Nonetheless, the autocorrelation amplitude 
was shown to decrease over time, indicating the presence of brightness flickering 
due to FRET (Table 6.1). This flickering was assigned to the reversible binding of 
TRPV1-C. In order to recover the characteristic binding time of the complex, we 
assumed D ≈ 0 and we fitted the correlation data at ρ = 0 to Eq. 6.12. We found out 
τb=16.4±4.0 s (Fig. 6.4B).  
Finally, the analysis of iMSD intercept with Y-axis highlighted that TRPV1-C has 
an apparent diameter of 360±40 nm, consistent with the size of caveolar regions 
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Table 6.1. Parameters derived from iMSD analysis. 
The rows indicate the different dynamic populations of TRPV1. For each population we 
report three conditions: basal, nocodazole-treated (+NDZ), and sphingomyelinase-treated 
(+SMase). Dynamic parameters are reported in columns: D=diffusion coefficient, 
α = anomalous diffusion exponent, δ = diameter of diffusing species, τB = characteristic 
binding time, and A = fractional correlation amplitude. The values are expressed as 
Mean±Standard Error. 
 
TRPV1 pool D (µm2/s) α  d (nm) τb (s) A (%)  
TRPV1-C 
~ 0 - 360±40 16.4±4.0 68±21 Basal 
* * * * 69±14 +NDZ 
* * * 2.9±2.1 88±08 +SMase 
TRPV1-T 
(9.0±2.6)⋅10-3 1.5±0.3 860±300 «10 ms or »60 s 19±16  Basal 
- - - - 0 +NDZ 
- - - - 0 +SMase 
TRPV1-I 
0.22±0.02  1 - - 13±09  Basal 
0.99±0.18 * - - 31 +NDZ 
0.10±0.04 * - - 12±07 +SMase 
* Values keeping equal at basal condition (obtained by STICS-FRET analysis) during the 
fitting  




Figure 6.1. iMSD-FRET analysis of TRPV1-caveolin-1 complex (TRPV1-C). (A) iMSD 
vs. time plot of FRET signal for the caveolin-1-EGFP/TRPV1-TagRFP pair in physiological 
condition. The constant iMSD clearly demonstrates that the complex is not diffusing in space, 
i.e. it is trapped within caveolin-enriched structures on cellular membrane. (B), Temporal 
evolution of the binding component: plot of G(0,0,τ) vs. time shows the decrease of 
correlation function in time.  
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6.2.2 Spatiotemporal organization of TRPV1-microtubule (TRPV1-T) 
complex 
The diffusion characteristics of the TRPV1-α−tubulin complex (TRPV1-T) were 
analyzed by FRET-iMSD in TIRF modality by using TRPV1-EGFP and TagRFP-
αT. Fitting of GFRET(ρ,τ) to Eq. 6.5 and 6.14 indicated the absence of FRET 
flickering and the presence of the sole diffusing component, thus suggesting that the 
complex binding time is much longer than the overall acquisition time (60 s). 
Remarkably, iMSD of TRPV1-T was found to be associated with a time dipendent 
hyperbolic growth (Fig. 6.2). This "super-diffusive" dynamic behavior is attributable 
to guided/active mobility (189). In this process we found out D=(9.0±2.6)⋅10-3 µm2/s 
and α=1.5±0.3 (Table 6.1). Interestingly, the analysis gave σ0 >> σxy : Eq. 6.6 
yielded ~800 nm as the dimension of super-diffusive TRPV1-T. This suggests that 
the interaction between TRPV1 and tubulin occurs over large sub-micron domains 
of the cell membrane. Consistently, a highly patterned signal, composed by several 
spots with 500-1000 nm size, was visible also in the static FRET image (§ 3.2.2 Fig 
3.9).  
 
Figure 6.2. iMSD-FRET analysis of TRPV1-microtubules interaction (TRPV1-T). iMSD 
vs. time plot for FRET signal between TRPV1-EGFP and TagRFP-αT in physiological 
conditions. The fitting shows that TRPV1-T undergoes a super-diffusion process within the 
cellular membrane. 
 
In Section 3.2.2 we demonstrated by FRET that a fraction of TRPV1 is bound to 
(at least) one microtubule chain. Literature data showed that the cytoplasmic tail of a 
single TRPV1 chain contains a binding stretch to the plus end of microtubules 
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(147). tICS results indicated that only the functional receptor interacts with, and it is 
stabilized by, microtubules. FRET-iMSD provided further biological insights on the 
TRPV1-microtubule interaction: TRPV1-T complexes are arranged 
supramolecularly over large membrane regions (500-1000 nm), and the diffusion of 
these rather large membrane islets is guided by microtubules. 
6.2.3 Fast- and brownian-diffusing TRPV1 pool 
The FRET and iMSD-FRET experiments highlighted the presence of the TRPV1 
complexes with caveolin-1 (TRPV1-C) and microtubules (TRPV1-T). To check 
whether these two subpools constitute the only dynamic populations of the receptor, 
we carried out iMSD measurements on the sole receptor (Fig 6.3A).  
 
 
Figure 6.3. iMSD analysis of TRPV1-YFP diffusion assuming only two species that 
contribute to the observed decay of autocorrelation function. (A) TIRF microscopy image 
of a CHO cell expressing TRPV1-YFP. (B) The spatiotemporal autocorrelation function at 
different times is shown (upper section) together with  with the corresponding Gaussian fit 
(middle section) and residues (lower section). Two dynamic components that account for 
binding and superdiffusion regimes are considered. Note the rather high residuals at short 
timescale <2 s. (C) Horizontal (ξ = 0) section of the residual plot of panel (B): the high 
residuals at short times are clearly visible.  
The autocorrelation function of TRPV1-YFP was initially fitted to a sum of two 
fixed components (Fig. 6.3B), one accounting for a sub-diffusive/binding regime 
(TRPV1-C) and the other for a super-diffusive regime with very long binding time 
(TRPV1-T). Inspection of the residuals highlighted that TRPV1-C and TRPV1-T 
are not enough to account for the experimental autocorrelation at times <2s 
(Fig.6.3C). Additionally the presence of a fast diffusing component was investigated 
by the “derivative” approach expressed by Eq. 6.9-6.10. G2D(ρ,τ) vs. τ was plotted 
for 500 nm < ρ < 1 µm (Fig. 6.4A), thus filtering out the “immobile” binding 
component TRPV1-C, visible only for ρ  ≤ σxy (§ 6.13). Then, the time at which the 
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autocorrelation showed a maximum ( ) was computed for each ρ value. For 
short times (<2 s), the plot of max




Figure 6.4. Disclosing of an isotropic TRPV1 component by iMSD analysis. (A) 
Representative average correlation functions of TRPV1 for distances between 500 nm e 1 um. 
The position of the maximum of the curves (ρm2) shifts at longer times (τm) increasing the 
spatial lag.. (B) When ρm2 is plotted vs. τm  (<1.2 s), a linear trend (R2=0.998) is clearly 
visible, indicating the presence of a Brownian-diffusing TRPV1 component. 
 
We should note that in this temporal range the guided diffusion by microtubules was 
spatially negligible (iMSD < 0.03 mm2/s) and TRPV1-T did not contribute to the 
observed iMSD. These date indicated the presence of a TRPV1 subpool diffusing 
isotropically with D=(2.2±0.2)⋅10-1 µm2/s. We denoted this subpool as TRPV1-I. 
Remarkably fitting the experimental G2D(ρ,τ) to a sum of three components (Fig 
6.5A), TRPV1-T, C and I always yielded very low residuals at any time, thus 
confirming the presence of the three subpools (Fig.6.5B). Table 6.1 reports the 
correlation amplitudes as fraction of the total correlation at ρ = 0 and τ = 0. 
Correlation theory shows that the inverse of correlation amplitudes is related to a 
number of factors including the mole fraction of the relevant diffusing component. 
Accordingly we investigated the dependence of the inverse of AT, AC and AI upon the 
total expression of the receptor, the latter being expressed by the overall 
fluorescence on the cell membrane. This analysis afforded a semi-quantitative 
maxτ
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picture on how the three TRPV1 pools were populated at different total receptor 
concentration. Remarkably, AC, AT were almost independent from fluorescence 
intensity of TRPV1-YFP (i.e. from the expression level of the receptor) (Fig 6.6A 




Figure 6.5 iMSD analysis of TRPV1-YFP diffusion assuming three species that 
contribute to the observed decay of autocorrelation function. (A) The spatiotemporal 
autocorrelation function at different times is shown (upper section) together with the 
corresponding Gaussian fit (middle section) and residues (lower section). For fitting, three 
dynamic components that account for binding, superdiffusion, and isotropic diffusion regimes 
are considered.. (B), Horizontal (ξ = 0) section of the residual plot as shown in panel (A): the 
low residuals at any time are clearly visible...  
 
This finding strongly suggests that the membrane concentrations of TRPV1-C and 
TRPV1-T are strictly regulated and do not follow changes in the expression level of 
the receptor. This feature is in keeping with the strict control over the diffusion 
behavior of these TRPV1 complexes, confirming that they play a relevant biological 
role. On the other hand, the progressive growth of TRPV1-I concentration with 
increasing expression level, together with its free isotropic diffusion, advocates a 
reservoir role for this subpool, which likely represents an immature form of the 
receptor.  
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Figure 6.6. Dependence of the amounts of TRPV1 subpools upon cellular expression 
level of the whole receptor. TRPV1-C (A) and TRPV1-T (B) membrane populations are not 
affected by the receptor expression level, as witnessed by the low linear correlation 
coefficients. (C) Unlike the other two components TRPV1-I population is almost linearly 
related to receptor expression level. 
 
6.2.4 Effect of microtubule disassembly or lipid-raft depletion on TRPV1 
diffusion 
In order to test the effect of microtubule disassembly or lipid-raft depletion on 
TRPV1 diffusion, we submitted cells to nocodazole and sphingomyelinase, 
respectively.  
Nocodazole treatment had two effects: 1) TRPV1-T pools disappeared, and 2) 
G2D(ρ,τ) could be fitted to a two components model entailing TRPV1-C and 
TRPV1-I (Fig 6.7A). Furthermore, in the absence of microtubules AC did not 
change, whereas an increase in AI was observed (Table 6.1). These findings support 
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the hypothesis of TRPV1-I as receptor reservoir. Notably, TRPV1-I was 




Figure 6.7. iMSD analysis of TRPV1-YFP diffusion in the presence of nocodazole. (A) 
The spatiotemporal autocorrelation function at different times is shown (upper section) 
together with the corresponding Gaussian fit (middle section) and residues (lower section). 
Two dynamic components that account for binding, and isotropic diffusion regimes are 
considered. The superdiffusive TRPV1-T was not considered for the absence of intact 
microtubules. The low residuals support our assumption. (B) Representative average 
correlation functions of TRPV1 for distances between 410 and 1310 nm e 1 um. The position 
of the maximum of the curves (ρm2) shifts at longer times (τm) increasing the spatial lag. (C) 
When ρm2 is plotted vs. τm  (<0.4 s). a linear trend (R2=0.995) is clearly visible, highlighting 
the isotropic diffusion of TRPV1-I (D=(0.99±0.18) µm2/s). 
 
Sphingomyelinase treatment hampered the formation of TRPV1-C, as witnessed 
by the significant 5-fold decrease of τb (Tab. 6.1). This result is consistent on the 
sphingomyelin-enriched raft nature of caveolae (190). Surprisingly, however, 
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sphingomyelinase treatment triggered the complete disappearance of TRPV1-T 
component. This result in turn dictates that the large membrane islets containing 
TRPV1-T must be stabilized by raft patches containing sphingomyelin. Inspection 
of fractional correlation amplitudes showed that the loss of TRPV1-T increased of 
TRPV1-C, with no concomitantly alteration of the TRPV1-I concentration (Table 
6.1). The diffusion coefficient of TRPV1-I, however, was radically decreased. This 
result might be explained by considering a general systemic influence on membrane 
fluidity by sphingomyelin. 
 
 
6.3 Concluding remarks 
In conclusion, in this chapter we targeted the full comprehension of TRPV1 
diffusion/interaction processes as well as its spatial organization on the membrane. 
This goal was pursued by the use of a novel image correlation approach, iMSD. 
iMSD includes both the spatial and temporal dimensions and it is suitable for 
determining diffusion laws of biomolecules in live cells. We demonstrated that 
iMSD can be proficiently combined with FRET to highlight the relationship 
between diffusion and spatial organization of the interacting/non-interacting 
receptor subpools. In particular, we showed that TRPV1 complexes with caveolin-1 
(TRPV1-C) and tubulin (TRPV1-T) are spatially-decoupled and follow distinct 
diffusion processes. TRPV1-C is almost immobile on the membrane, being located 
in membrane regions with size comparable or smaller than the resolution of the 
imaging system (250-300 nm). Also TRPV1-C is characterized by a reversible 
association/dissociation process over a few seconds. TRPV1-T, instead, assemble 
over large membrane patches (up to 900-1000 nm). The membrane diffusion of the 
these patches is guided by microtubules. The TRPV1-T complex is stable for times 
longer than 60 s but microtubule depolymerization leads to the disassembly. On the 
other hand, depletion of sphingomyelin to hamper lipid-raft formation leads to a 
faster association/dissociation equilibrium of TRPV1-C and the disassembly of 
TRPV1-T. The latter result suggests that the large islets where TRPV1-T assembles 
are critically dependent on the stability of membrane rafts.  TRPV1 comprises a 
third “immature” subpool, TRPV1-I, which moves isotropically within the 
membrane and plays the role of receptor reservoir. Differently from TRPV1-C and 
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TRPV1-T, whose membrane contents are strickly regulated to fulfill their biological 
roles, TRPV1-I concentration increases with receptor expression. 
The presence of three receptor subpools is apparently in contrast with previous 
tICS results, which indicate the presence of two main autocorrelation components. 
We should note, however, that the reversible equilibrium of “immobile” TRPV1-C 
is detected by tICS as temporal dissipation of correlation. Thus, the “fast” 
component detected by tICS averages the fast isotropic diffusion of TRPV1-I and 
the reversible binding of TRPV1-C. Consistently, no interaction of the “fast” 
component with microtubules was highlighted by tICS-FRET ($ 4.3.2). Instead, the 
“slow” component detected by tICS and tICS-FRET fully identifies with TRPV1-T. 
 
 
6.4 Experimental procedures 
6.4.1 Cell Cultures, Constructs and Transfection.  
CHO K1 cells were provided by American Type Culture Collection (CCL-61 
ATCC) and grown in Dulbecco’s modified Eagle medium F-12 nutrient mix (D-
MEM/F-12, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, 
100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen). For live imaging, 12
104 cells were plated 24 hours before transfection onto a 35-mm glass-bottom dish 
(WillCo-dish GWSt-3522). Transfections of all constructs were carried out using 
Lipofectamine reagent (Invitrogen) according to the manufacturer’s instructions. In 
all experiments, cell were maintained at 37°C in a 5% CO2 atmosphere. For 
experiments of depolimerazation of microtubules cells were incubated in fresh 
medium with 3mg/ml of nocodazole (Sigma Aldrich) for 10 minutes.  
Sphingomyelin on plasma cellular membrane was depleted by 1 U/ml 
Sphingomyelinase from Bacillus cereus (Sigma Aldrich) for 30 minutes. All the 
details about TRPV1-YFP construct are described in (145). The TRPV1-EGFP 
construct was generated by site direct mutagenesis of p-TRPV1-E0GFP as described 
in §3.4.1. The TRPV1-TagRFP construct was obtained by sub-cloning TRPV1 
sequence from TRPV1-YFP construct in pTagRFP-N (§ 3.4.1) TRPV1-YFP is a 
kindly gift from Wei Cheng (159). TagRFP-αT construct  was purchased by 
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Evrogen (FP145).  The caveolin-1-EGFP plasmid was a kindly gift from 
L.Pelkmans (191) 
6.4.2  iMSD and iMSD-FRET.  
Measurements were carried out with a Leica AF6000 fluorescence microscope in 
Total Internal Reflection mode (TIRF), with a penetration depth of the evanescent 
wave less than 100 nm. Fluorescence was collected by using a 100x (NA 1.47) oil-
immersion objective and was recorder cooled EM-CCD (Hamamatsu C1900-13). 
for STICS-FRET measurements on cell co-expressing TRPV1-EGFP and TagRFP-
αT, and cell co-transfected with TRPV1-TagRFP and caveolin-1-EGFP  excitation 
at 488 nm was used and emission was collected using a 502 dichroic mirror (Leica 
Microsystem) and filtered by a Semrock FF01-641/75-25 filter.  
In detail, where not differently stated, TIRF time series were acquired at 10 ms 
time resolution by using the overlapping mode of CCD camera. Typical time series 
lasted at least 6000 frames (~60 seconds). iMSD analysis was performed by an 
custom-made MatLab library as previously shown (186). The contribution to the 
STICS function of an immobile fraction of particles was removed by proper filtering 
(161). Additional possible artifacts due to average image intensity temporal drift, 







7    
  
TRPV1 organization on plasma membrane: 
general model and conclusions 
In chapter 3-6 we described several experimental results that shed light on the 
previously unknown diffusion/binding interplay of membrane TRPV1. In this final 




7.1 Molecular association of membrane TRPV1 with itself and 
other proteins 
In vitro biochemical assays (73) and colocalization analysis on fixed cells (25) 
highlighted that TRPV1 and microtubules interact together in some way. Other 
experiments identified the cytoplasmic C-terminus of TRPV1 as hot-spot for 
binding to β-tubulin (74). The possible interaction between TRPV1 and 
110 TRPV1 organization on plasma membrane: general mode1 and conclusions 
 
microtubules is particularly intriguing, since it would provide a connection between 
nociception and cytoskeletal remodeling. This was our starting point. 
In this thesis we demonstrated for the first time in living cells the effective binding 
between basal or agonist-stimulated TRPV1 and microtubules. This result was 
accomplished by observing FRET between TRPV1 and α-tubulin labeled with 
optically-complementary fluorescent proteins. High-resolution FRET maps showed 
that the binding interactions occur within large membrane islets of size up to 900-
1000 nm. Notably, microtubule disassembly (induced by nocodazole) led to the 
complete disappearance of the FRET signal. These findings demonstrated that: 1) 
TRPV1-tubulin binding takes place only when the latter protein is polymerized in 
functional microtubules, 2) the interaction between TRPV1 and microtubule is 
independent from the channel-activation status, and 3) the binding regions consist of 
supramolecular arrangement of several TRPV1 receptors. The TRPV1-microtubule 
complex was named TRPV1-T. 
Earlier reports highlighted the positive role of TRPV1 activation in promoting 
microtubule disassembly and remodeling. Our results raise the question whether 
microtubules could be an essential factor to stabilize TRPV1, through binding, in its 
functional form. Remarkably, we found out that microtubule depolymerization 
yields a large fraction of membrane-immobile receptor, as well as a considerable 
loss of TRPV1 activity in terms of Ca2+ influx upon stimulation. By Fluorescence 
Anisotropy Analysis (FAIM) we revealed that the immobile fraction is composed by 
large receptor aggregates made up of several (likely ≥10) TRPV1 units. We applied 
FAIM and moment analysis of fluorescence fluctuations (N&B analysis) also to 
study TRPV1 oligomerization in the presence of integer microtubules, highlighting 
that TRPV1 at basal state can aggregate only up to tetramers. According to 
literature, functional TRPV1 has a well-defined tetrameric structure on the 
membrane(79).  
The activation of the TRPV1 due to noxious stimulation is followed by the 
attenuation of the excitability of nociceptive sensory neurons, making nociceptors 
partially or totally refractory to subsequent stimuli (86). Depending on the refractory 
period, which can range from minutes and hours up to days, this phenomenon is 
known as acute desensitization, down-regulation, or defunctionalization (152). 
While Ca2+-dependent mechanism of acute desensitization is known (92), long-term 
TRPV1 desensitization is poorly understood. It was hypothesized that long-term 
desensitization might involve TRPV1 withdrawal from the cell surface. 
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Interestingly, Sanz-Salvador et al. visualized the effective internalization of the 
receptor upon agonist stimulation and showed its independence from clathrin 
endocytotic pathway, although they were unable to reveal the actual mechanism 
(152). In this work, we demonstrated that caveolar endocytosis is an effective long-
term desensitization mechanism of TRPV1. For the first time caveolin-1 (one of the 
most important protein in caveolar endocytosis) was identified by FRET as a 
molecular interactor of TRPV1 at membrane level and, most likely, as a powerful 
modulator of receptor long-term desensitization. In fact, we demonstrated that 
TRPV1 stimulation leads to cell internalization and positive co-localization of 
intracellular TRPV1 with caveosoma structures. The TRPV1-caveolin-1 complex 
was named TRPV1-C. 
 
 
7.2 Membrane dynamics of TRPV1 
 
By combining FRET with temporal image correlation analysis we were able to 
identify the dynamic features of TRPV1-T with respect to the whole membrane 
receptor pool. At first, we looked only at the temporal behavior of fluorescence 
fluctuations due to protein diffusion (tICS analysis). Albeit tICS did not provide the 
subtle details of TRPV1-T membrane dynamics, it clearly indicated that TRPV1-T 
should be identified with the functional (i.e. capable of agonist stimulation) form of 
the receptor at basal state, which is characterized by a very slow mobility within the 
bilayer (D~10-5 µm2/s).  
Next, we aimed at understanding the whole dynamic network of TRPV1 
interactions within the membrane. For this goal, we applied a novel correlation 
analysis (iMSD) based on spatio-temporal image correlation spectroscopy (STICS). 
iMSD was also combined with FRET to follow specifically the dynamic features of 
TRPV1-T and TRPV1-C. iMSD-FRET highlighted intriguing dynamic and spatial 
features of TRPV1-T. Each TRPV1-T system does not move as single complex, but 
it participates to a concerted movement of large membrane islets (up to 900-1000 
nm). These islets diffuse slowly within the cell membrane and are actively driven by 
integer microtubule chains. Notably, sphingomyelin is a necessary constituent of 
these islets, as demonstrated by the disappearance of the TRPV1-T pools upon 
sphingomyelin digestion by sphingomyelinase. The presence of sphingomyelin 
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suggests that lipid rafts are essential constituents of these large islets, in agreement 
with a previous study that pointed out the correlation between cholesterol and 
TRPV1 functionality (70). Although more experimental data are necessary to clarify 
the structural features of TRPV1-T, we can sketch a first model in which many 
TRPV1 molecules move, in a coordinated way, either along microtubule chains that 
reside underneath the membrane, or tethered to microtubule chain-ends. The 
functional role of TRPV1-T is witnessed also by the strict control over its membrane 
concentration by the cell. 
Conversely, FRET-iMSD results showed that TRPV1-C is confined into small 
sphingomyelin-enriched membrane patches likely identifiable with caveolar 
structures. These structures were found to be almost immobile for times up to 1 min. 
The binding of TRPV1 to caveolin-1, however, displayed a reversible dynamics 
with a characteristic time of about 16 s. Analysis of autocorrelation amplitude 
highlighted that TRPV1-C concentration on the membrane is independent of the 
expression level of the receptor. This indicates a strict biochemical control by the 
cell over the amount of membrane TRPV1-C, in order to fulfill its biological role. 
Significantly, upon agonist (RTX) administration, TRPV1 and caveolin-1 were 
mostly removed from the cell membrane and translocated to the cell interior in 
caveolar structures. These findings suggest that TRPV1-C is the first step towards 
caveolar endocytosis of the receptor and, likely, its desensitization. 
One may question whether the regions containing TRPV1-C are subsets of the 
large TRPV1-T islets, on account of the recognized interplay between caveolae and 
microtubules (55,193). Our findings suggest that TRPV1-C and TRPV1-T are 
spatially decoupled: in fact, the iMSD trace at time zero of TRPV1-C did not 
display large patch-like arrangements as in the case of TRPV1-T, a feature that 
would be expected if the two TRPV1 pools were accommodated in the same 
membrane location. Additionally, microtubule disassembly did not affect the 
amplitude of TRPV1-C correlation.  
Finally, a third, isotropically- and fast-moving TRPV1 subpool was identified by 
iMSD analysis and named TRPV1-I. Notably, TRPV1-I concentration on the 
membrane was found to depend on the expression level of the receptor. This finding 
strongly suggests that TRPV1-I is not directly involved in the receptor functional 
role, but represents a TRPV1 “reservoir”. TRPV1-I could be a precursor of the 
TRPV1-T functional receptor: in fact, microtubule disassembly by nocodazole leads 
to the conversion of TRPV1-T into the freely-moving TRPV1-I subpool. 
 




7.3 Functional model of TRPV1 
Recently, a working model of membrane TRPV1 was presented. This model 
accommodates most of the results we presented in Chapters 3-6 and it integrates 
additional biochemical data published by other authors on the phosphorylation of 
the receptor (51). According to this model, TRPV1 assembles firstly as a dimer, 
then tetramerizes, and eventually is sensitized towards agonist activation by 
phosphorylation carried out by kinases on the cytoplasmic C-terminus of the 
receptor. In this model, microtubules promote tetramerization but are detached from 
TRPV1 upon phosphorylation. This model is a convenient starting point to interpret 
our intriguing iMSD data. In fact, the identification of the sensitized receptor with 
TRPV1-C would explain the spatial decoupling of TRPV1-C and TRPV1-T. 
Enabling sensitization upon phosphorylation and de-sensitization upon 
internalization would account for the fine regulation of receptor activity that is 
required to fulfill its biological role. Further activation of TRPV1 generates also 
Ca2+ influx that causes rapid disassembly of microtubules and shifts the equilibrium 
towards the tubulin dimer as a feedback mechanism (Fig. 7.1). Vice-versa, 
independent microtubule disassembly leads to TRPV1 aggregation and the 
impairment of receptor function. On overall, this subtle molecular interplay oversees 
the correct functioning of the receptor and prevents the over-activation of the cell 
response following noxious stimuli. 
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Figure 7.1 A general model depicting TRPV1 activity and functionality. The life-cycle of 
TRPV1 is described starting from the upper left panel and moving counter-clockwise. TRPV1 
is initially monomer after expression and proteic maturation. Then, the receptor forms stable 
dimers that represent an immature form of the receptor. At physiological condition 
microtubules filaments attach to dimers and stabilize TRPV1 in tetrameric form.  
Translocation of the TRPV1 tetramer on caveolar regions, dissociation of microtubules and 
phosphorylation is required to sensitize the receptor towards external signals. Agonist 
stimulation of TRPV1 results in Ca2+ influx and a cascade of signaling events. Yet, after 
prolonged activation the desensitization mechanisms of TRPV1 take place and involve 







Image Correlation spectroscopy: mathematical 
foundations 
The starting point of ICS analysis is the generalized spatiotemporal correlation 
function (161): 
 G s,τ( ) =
Fa r, t( ) ⋅Fb r+ s, t +τ( )
Fa r, t( ) t ⋅ Fb r, t +τ( ) t+τ
−1 , [A.1] 
where ( )tF ,r  is the intensity at position r in the image recorded at time t, and 
( )
t
tF ,r  is the average intensity of that image at time t (i.e. average is taken only 
on spatial dimensions). s and τ represent the spatial and temporal lags of correlation, 
respectively. To avoid confusion, the spatial components of the vectors r and s will 
be distinguished and denoted as (x,y,z) and (ξ,χ,ζ), respectively. For generality, we 
introduce the subscripts a and b in Eq. 2.7 to refer to two distinct wavelength 
detection channels. If a=b, Eq.A.1 expresses the autocorrelation function of the 
system; conversely, a≠b refers to a crosscorrelation function. In the following, only 
the autocorrelation function will be considered and the subscripts a and b are 
dropped. 
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Starting from the definition of spatiotemporal autocorrelation (Eq. A.1) it can be 
demonstrated that ( )τ,sG  is expressed by a sequential convolution (⊗ ) of two 
functions, ( )τ,sp  and ( )sW  (186), according to: 
 
 ( ) ( ) ( ) ( )[ ]ssss WWp
N
G ⊗⊗= τγτ ,, . [A.2] 
The terms constituting Eq. A.2 deserve particular attention: 
• ( )τ,sp 	   is a probability function describing the dispersive dynamics of 
diffusing molecules. Actually, ( )τ,sp 	  corresponds to the Green’s function 
that is adopted for solving the Fick’s equation once boundary conditions 
are stated. Here, an important case is represented by isotropic free 
diffusion. This condition holds whenever diffusing molecules have size 
negligible as compared to the focal volume, and the latter is in turn 
spatially negligible as compared to whole diffusion volume. In such a case, 
the Green’s function of Fick’s equation in a space of dimensionality k 




















ss  [A.3] 
• ( )sW 	  is the fluorescence intensity distribution corresponding to the imaged 
focal volume in CLSM or TIRFM systems, and corresponds to the Point 
Spread Function (PSF). In most systems, ( )sW 	   is well approximated by a 
Gaussian distribution (see Eq. 2.2, §2.1.1)	   
• γ is a scalar related to the actual shape of the PSF. 
Before trying to solve Eq. A.2, an important point has to be mentioned. In all ICS 
techniques the autocorrelation is calculated on a temporal stack of images collected 
in a given specimen area without modifying the focal z position of the objective. So, 
we have always ζ=0, and the autocorrelation function actually becomes function of 
two spatial coordinates only, i.e. ( ) ( )τχξτ ,,, GG →s . These two coordinates 
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represent the spatial lags of correlation within the optical xy plane containing the 
image. 
Integration of Eq. A.2 is possible only for those special cases for which analytical 
forms of ( )τ,sp  and ( )sW  are available. A very important example is represented by 
the combination of isotropic free diffusion (Eq. A.3) and Gaussian PSF. In such a 
case, for 3D diffusion (k=3 in Eq. A.3), we have: 
 













































,  [A.4] 
where G(0,0,0) is the zero-lag amplitude, S is the ratio between the axial and the 
radial resolution of the optical setup ( xyzS σσ=  in our notation), and τD is the 
characteristic diffusion time of the molecules under observation.  
Many interesting cellular processes take place in membrane compartments, i.e. 
within extended planar cellular structures. Here, diffusion must be considered as 
occurring in a 2D plane only, which is conventionally considered as coinciding with 
the xy plane of the images. In such a case, A.4 is recast as: 
 





































Regardless of the dimensionality of the diffusion space, τD is related to the 









=  [A.6] 
Often, in biological contexts, the ideal case of isotropic diffusion does not apply, 
because the movement of the molecules is restricted or the mobility shows strong 
local changes. These deviations may be due to the confinement of the molecules 
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within cellular compartments or lipid domains of membranes, but also to 
nonspecific interactions with other molecules or cellular structures. In such cases, 
Eq. A.4 and A4.5 generalize to Eq. A.7 and A.8, respectively: 
 



























































































































( . [A.8] 
In Eq. A.7 and A.8 the anomalous diffusion behavior is cast into the α coefficient. 
Isotropic diffusion holds for α = 1; the case α > 1 is typical of “guided diffusion”, 
i.e. diffusion partially driven by energy-dependent processes, whereas the case α < 1 









= . [A.9] 
Notably, for α ≠ 1, D stands for an empirical transport coefficient of fractional time 
dimension (in some cases denoted as apparent diffusion coefficient or Dapp). 
So far, fluorescence fluctuations were attributed to diffusion motion only. 
However, diffusion-independent molecular mechanisms that change the 
fluorescence brightness also contribute to fluctuations, and they are inevitably 
recorded into the autocorrelation function. This phenomenon is called brightness 
flickering. In the simplest case brightness flickering is accounted for by adding an 
exponential term to the diffusive autocorrelation function, i.e.: 
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τχξτχξ exp,,,, 22 DD GG , [A.11] 
where τΦ is the characteristic time of brightness flickering and GD-3 and GD-2 are 
given by Eq. A.8 and A.9, respectively. Despite its simplicity, the exponential term 
describes properly a number of photophysical phenomena, including quenching or 









Photoswitching of E222Q GFP mutant linked to 
TRPV1 for advanced imaging applications 
The discovery of phototransformable FPs (PTFPs) from Anthozoa species 
triggered a revolution in the field, notably by enabling single-molecule localization-
based super-resolution microscopy (196,197). Three types of phototransformations 
can be distinguished: photoactivation and photoconversion are nonreversible 
processes that result from covalent modifications of the FP matrix, whereas 
photoswitching refers to the reversible transition between a fluorescent on-state and 
a non-fluorescent off-state. 
Reversible photoswitching (photochromism) in FPs has first been observed for 
yellow derivatives of Aequorea victoria GFP (YFP) at single-molecule level by 
alternating cyan (488 nm) and violet (405 nm) excitation (198). Bulk 
photoswitching at room temperature was discovered also for other GFP derivatives, 
notably CFP (199) and several yellow variants such as, Citrine (199), E2GFP (200), 
and YFP-10C (201). In all cases, the photoswitching contrast was not high, on 
account of the coexistence of non-photoswitchable populations of molecules. 
Reversible light-induced cis-trans isomerization of the chromophore and/or 
chromophore protonation was hypothesized as the most likely reasons for the 
observed photochromism. 
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The discovery of FPs from Anthozoa species such as corals or anemones triggered 
a considerable boost in FP research. The first photochromic optical highlighter for 
biological experiments was obtained upon engineering a Pectiniidae coral FP, 
yielding the well-known photochromic Dronpa (202). The creation of Dronpa was 
followed by the introduction of other photochromic proteins exhibiting improved 
properties such as better fluorescence brightness, enhanced switching contrast, 
tunable switching quantum yields, increased fatigue-resistance, or red-shifted 
emission color (203). Mechanistic investigations of some of these photochromic 
proteins, generally based on a combination of crystallographic, spectroscopic, and 
molecular dynamics approaches (204-209), suggested photoswitching mechanisms 
based on coupled cis-trans isomerization and protonation changes of the 
chromophore. 
In this context, we recently found that the E222Q amino acid replacement confers 
efficient photochromicity in otherwise poorly switchable green fluorescent protein 
variants of different optical properties (210). The generality of E222Q substitution 
was tested on both green and yellow FP mutants. 
Here we shall present the photochromic EYQ1, a yellow-emitting E222Q mutant 
which was fused to TRPV1 in order to investigate the receptor distribution on cell 
membrane by means of novel imaging approaches that take advantage of the 




B.1.1 Optical properties of EYQ1 mutant in the native state 
With respect to wtGFP, EYQ1 is characterized by three aminoacid replacements 
(F64L/T203Y/E222Q). The T203Y mutation confers the yellow-emitting properties 
to the protein (126), whereas the E222Q is at basis of its photochromicity; F64L is 
known to reduce the chromophore maturation time (103).  
Three ground states characterized by different protonation patterns of the 
chromophore and nearby Glu222 contribute to the 400–530 nm region of the 
absorption spectrum of GFPs (125). .Nonetheless, the removal of Glu222 leads to 
only two protonation states affecting the protein optical properties: (i) neutral 
chromophore (protonated phenol group), hereafter denoted as A state, and (ii) 
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anionic chromophore (deprotonated phenol group), hereafter denoted as B state. 
State A absorbs at 400–410 nm (Fig B.1 full red line) and, in EYQ1 protein, is 
practically non-fluorescent (quantum yields about 10-3). State B absorbs at 480–500 
and it emits yellow fluorescence in EYQ1 (λem = 525 nm). The quantum yields of B 




Figure B.1. Optical properties of EYQ1. Absorption (full lines) and emission spectra 
(dotted lines). 
 
States A and B can be reversibly interconverted by changing the pH of the 
solution surrounding the protein. Removal of E222 or its stabilization in the neutral 
form has been repeatedly shown to favor the B state from a thermodynamic point of 
view (125,211). Indeed, EYQ1 has pK = 6.87 (210). Thus, at physiological pH (7.2–
7.4) state B is predominant.  
B.1.2 Photoswitching of EYQ1 mutant 
At physiological pH and above, illumination near the maximum wavelength of the 
B state of EYQ1 leads to a progressive decrease of fluorescence both in vitro and in 
cells. Analysis of the in vitro absorption of EYQ1 showed that the fluorescence 
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decrease was associated with a parallel decrease of the B absorption band and an 
increase of a nonfluorescent state (hereafter denoted as At) located at 400–415 nm 
(Fig. B.2). Upon irradiation of At, the B state was partially restored, as well as the 




Figure B.2. On→off photoswitching of EYQ1. Photoswitching of EYQ1 in vitro at pH 7.4 
upon illumination at 514 nm (0.5 W cm-2) followed by absorption (full lines) and emission 
(λex = 476 nm, dotted lines) spectra taken at different times. Photoswitching leads to 
population decrease of cis anionic B state (λ = 510 nm) and to population increase of trans 
neutral At state (λ = 413 nm). The latter state is non-emissive, and global EYQ1 fluorescence 
decreases proportionally to the deployment of emissive B state (inset plot). 
 
Actually, a photostationary condition, for which the on- and off-switching rates 
compensate each other, was eventually reached at any illumination wavelength 
within the absorption range of the B band. As the switching rate is linearly 
proportional to the number of absorbed photons, the fraction of photoswitched 
protein depends on the overlap of B and At absorption bands (212). 
On↔off photoswitching experiments on the protein entrapped in a polyacrylamide 
gel showed that a minor fraction (≤3%) of the protein was irreversibly 
photobleached at each cycle (this figure is called fatigue resistance) (Fig. B.3). 3% 
of signal loss at each cycle means that more than 70 cycles are required for the 
fluorescence to drop below 10% of the initial value (213). Note that the observed 
fatigue resistance is comparable to that of photochromic FPs widely applied to 
super-resolution and pulse-chase labeling studies (214). 
Interestingly, the photoconverted At state of EYQ1 relaxed thermally back to the 
initial cis state (B) after the illumination had stopped. The thermal decay followed a 
first-order kinetics with relaxation time constant related to the pH of the solution 
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(210). Similarly to what proposed for mutants from Clavularia (206) and Dronpa 
(205), this behavior was accounted for by the ionization of the chromophore in 
the trans state. In such a case, different energy barriers between trans 
and cis configurations exist for the protonated and anionic chromophore states, 
leading to thermal relaxation with pH-dependent rates. This hypothesis was 
experimentally demonstrated by coupled photoconversion/pH-jump experiments, 
and the pH-dependent ionization site was assigned to the phenolic function of the 
EYQ1 chromophore. Significantly, the trans form of the chromophore displayed a 
much higher pK as compared to the cis form (+2-3 pH unit), presumably owing to 
the lack of surrounding proton acceptor residues. 
 
 
Figure B.3. Photochromic behavior of EYQ1 (A) Photoswitching scheme of the yellow 
photochromic mutant EYQ1. Switching was carried out by alternating 514 and 405 nm 
excitation; fluorescence read-out was provided by continuous 514 nm excitation. Note that 
illumination at 514 nm was tuned to obtain concomitant switching off and fluorescence read-
out. (B) Photoswitching of EYQ1 immobilized in a polyacrylamide gel at pH 7.8 imaged by 
confocal microscopy A 13.1 µm × 13.1 µm was photoswitched according to the scheme of 
panel (A). Light intensities at focal plane were 0.8 kW/cm2 for 514 nm and 0.06 kW/cm2 for 
405 nm. Scale bar = 5 µm. (C) EYQ1was photoswitched according to the scheme of panel 
(A). At the bottom of the panel, the alternating sequence of 514/476 and 403 nm illumination 
is pictorially represented by green/cyan and violet ellipses. Light intensities at focal plane 
were 20−50 kW/cm2 for 514 nm and 2 kW/cm2 for 403 nm (Adapted from (210)). 
These findings led to a photophysical model that successfully rationalized all 
experimental results on EYQ1 and other E222Q proteins (Figure B.4) (215). 
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Natively, the chromophore has a cis stereochemistry and is characterized by a pH-
dependent equilibrium between a neutral phenol (protonated) state A and a 
phenolate (anionic) state B shifted towards B at physiological pH (pKcis EYQ1 = 
6.87 (210)). Only B is fluorescent (yellow), probably because the lack of E222 
forbids the ESPT mechanism from the neutral state A (216). Illumination at B 
maximum wavelength (510 nm) yields cis→trans photoisomerization of the 
chromophore. On account of its significantly lower acidity (pKtrans ≥ pKcis + 3), only 
the trans neutral chromophore (state At) becomes populated at pH < 9.  
 
 
Scheme B.4. Photoisomerization of E222Q GFP mutants. Natively, the protein has a cis 
chromophore charachterized by two fundamental states differing for the protonation state: 
neutral (A) and anionic (B). Interconversion between A and B at ground state is characterized 
by pKa values in the 6-7 range. Illumination of B state leads to cis→trans photoisomerization 
to dark At state for pH < 9. Illumination of At leads to trans→cis photoisomerization to 
emissive B state. These two photoprocesses are at basis of the on↔off photoswitching. The 
trans chromophore has a much higher pKa (denoted as pKt) than the cis form. Thermal 
relaxation back from trans to cis has a rather low activation energy barrier for the anionic Bt 
state (relaxation times of a few tens of second), whereas it is strongly unfavored for At 
(relaxation times of hours). 
 
Similarly to A, At absorbs at 400–410 nm and is non-fluorescent; hence, the 
photoisomerization results in the protein switching from an on state to an off state. 
The optical similarity between different stereochemical configurations (cis/trans) of 
the neutral state was reported also for Dronpa (217). Analogously, the trans anionic 
state of the chromophore (Bt) has optical properties very similar to B. Once in the 
trans form, the chromophore can return to the cis configuration in two ways: (1) by 
photoisomerization upon illumination at maximum wavelength of the predominantly 
EYQ1                                                                                                                                      127 
 
populated trans state or (2) by thermal relaxation (all calculations point out that the 
trans states have a larger free-energy than the cis states (212)). The first pathway is 
at basis of the observed efficient photochromic properties and, at pH where the B 
and At states are stabilized (between 7 and 9), allowed for on↔off cycling of 
fluorescence. The complete kinetic analysis of photoisomerization showed that B 
conversion is associated with switching yields of 2×10-4, whereas back-
photoisomerization of At and Bt states displayed switching yields between 4×10-3 
(210). 
The second pathway is pH-dependent, as the energy barrier for thermal 
isomerization between the Bt and B states is much less than between the At and A 
states. Thus, the thermal relaxation rate is practically proportional to the population 
of Bt, which is in turn modulated by pH. Note that the knowledge of the spontaneous 
thermal relaxation rate from photoconverted states is essential to plan the 
application of any photochromic mutant to imaging studies, because it defines 
(together with irreversible photobleaching) the time-window of stable non-emission 
(or emission for inverse photochromic mutants such as Padron (208)) from single 
molecules as well as from large molecular ensembles (e.g. subcellular regions). In 
particular we found out that trans dark states of EYQ1 are stable for several minutes 
at physiological pH. 
For further applications in the cellular context, where pH uniformity is not granted 
in all locations, we set out to investigate whether At or Bt, are the primary product of 
photoisomerization of EYQ1 (and other switching variants). By flash-photolysis it 
was found that photoisomerization of B yields At, thus implying that the cis-trans 
isomerization is concomitant with the change in chromophore protonation state. 
Although the experimental set-up did not permit the visualization of the state 
populations in the first 2 µs after photoswitching, these results strongly support a 
coordinated isomerization/protonation mechanism from B excited state (B*) (158). 
Significantly, some authors have suggested that, in the cis-trans photoswitching of 
other photochromic fluorescent proteins (e.g. Dronpa), the protonation and 
isomerization are two closely related events that take place in a very short time 
delay (218,219). This observation suggests an impressive degree of structural and 
photophysical resemblance among fluorescent proteins whose primary sequences 
display often a low degree of similarity. 
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B.2 TRPV1-EYQ1 for Superresolution Optical Fluctuation 
Imaging (SOFI)  
B.2.1  SOFI 
Super-resolution fluorescence microscopy overcomes the diffraction resolution 
barrier and allows investigation of mesoscale/nanoscale features with enhanced 
spatial detail. In general, all of these approaches generate “diffraction-unlimited 
images” by using the physical properties of fluorescent probes to distinguish 
emissions from two nearby molecules within a diffraction-limited region. These 
super-resolution approaches can be divided into two primary classes (220). The first 
category is constituted by patterned illumination. In such a way, not all molecules 
emit simultaneously, thereby achieving sub-diffraction limit resolution. This 
category includes stimulated emission depletion (STED) microscopy (221,222) and 
the related RESOLFT technology (223) as well as saturated structured illumination 
microscopy (SSIM) (224,225). The second category takes advantages of single-
molecule imaging, using photoswitching or other mechanisms to stochastically 
activate individual molecules within the diffraction-limited region at different times. 
Images with subdiffraction resolution are then reconstructed from the measured 
positions of individual fluorophores. This second class includes stochastic optical 
reconstruction microscopy (STORM) (226),  photoactivated localization microscopy 
(PALM) (196), and fluorescence photoactivation localization microscopy (FPALM) 
(197). Although these two families use different approaches to accomplish 
subdiffraction resolution, they share important characteristics. Indeed, in both cases, 
a physical or chemical property of the fluorophore is used to image it in different 
states (i.e., “on” and “off”), enabling them to be resolved from each other (227). 
A recent addition to this field is Superresolution Optical Fluctuation Imaging 
(SOFI), based on the statistical analysis of temporal fluorescence fluctuations. SOFI 
does not require specialized equipment and can produce subdiffraction images over 
a broad range of imaging conditions, including low signal-to-noise and high 
background (228,229). In SOFI, a dataset of tens or hundreds of images is acquired 
at high speed, using photochromic fluorophores that can switch between a 
fluorescent and nonfluorescent state in a stochastic way (230). In intensity images, 
the signal in each pixel is given by the superposition of the fluorescence originating 
from different, nearby emitters. In a SOFI image each pixel is associated with a 
value that is obtained from the nth-order cumulant of the original pixel time series. 
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The nth-order cumulant (a quantity related to the nth-order correlation function) 
filters the photoswitching intensity signal in such a way that only highly correlated 
fluctuations emerge. The fluorescence signal contribution of emitters in neighboring 
pixels will yield poor correlation values, thus leading to an increased resolution 
(231). The exact resolution improvement depends on the order of the cumulant 
analysis (228). In addition to robust spatial resolution improvements, SOFI allows 
improved contrast, background rejection, and favorable temporal resolution (229). 
Whereas SOFI can be performed on any sufficiently sensitive imaging system, 
including confocal systems, in practice it is most conveniently applied to wide-field 
imaging systems, owing to the increased efficiency afforded by the parallel read-out 
of multiple pixels. 
The underlying theory can be described (231) starting from a sample of N single, 
independently fluctuating emitters, located at position kr  (Fig. B.5) and having a 
time-dependent molecular brightness )(tskk ⋅ε . In this case, the resulting 
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Figure B.5. Principle of SOFI. (A) Emitter distribution in the object plane. Each emitter 
exhibits fluorescence intermittency, which is uncorrelated with the others. (B) Magnified 
detail of the dotted box in panel A. The signal from the emitter fluorescence distribution is 
convolved with the systems PSF and recorded on a subdiffraction grid (e.g., pixels of the 
CCD-camera). Two neighboring emitters, for example, cannot be resolved because of the 
optical diffraction limit. The fluctuations are recorded in a movie. (C) Each pixel contains a 
time trace, which is composed of the sum of individual emitter signals. (D) The second-order 
correlation function is calculated from the fluctuations for each pixel. (E) The SOFI intensity 
value assigned for each pixel is given by the integral over the second-order correlation 
function. The second-order correlation function is proportional to the squared PSF, thus 
increasing the resolution of the imaging system by a factor of . Taken from (231). 
 
We shall assume that the positions of emitters do not change during the image 
acquisition; temporal changes are caused only by emission blinking.  
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The fluorescence signal ),( trF at position r and time t is given by the convolution 
of the system’s PSF )(rU and the fluorescence source distribution (Eq. B.1 and Fig 
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Assuming that the sample is in stationary equilibrium during acquisition, the 
fluctuations can be expressed as zero-mean fluctuations: 
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...  denotes time averaging. The second-order autocorrelation function 
),(2 trG is then given by (Fig. B.4D): 
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In eq. B.4 we assumed that the emission of different emitters is not correlated in 
time so that all cross-correlation terms )()( tsts kj τδ + with j≠k vanish. The 
second-order autocorrelation function thus appears as a simple sum of the squared 
PSF, weighted by each emitter’s squared brightness and molecular correlation 
function )()( tsts kk τδ + . 
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The value of ),(2 trG for a time lag τ defines a SOFI image, the only difference 
between each image being the weighting of the squared PSF with the molecular 
correlation function.  
If the original PSF of the optical system can be approximated by a 3D Gaussian 
distribution, it follows from Eq. B.4 that the width of the “new” PSF is reduced by a 
factor of  along all three dimensions, thus increasing the optical resolution of the 
second-order SOFI image. Because the second-order correlation function involves 
the square of the PSF, it is natural to look into higher-order correlation functions, 
generate higher powers of the PSF, and therefore further increase the resolution. 




trFtrFtrFrG ),(),(),(),...,,( 1111 −− +⋅⋅⋅+= τδτδδττ  [B.5] 
Gn can be easily computed in a straightforward manner, because the above 
formula states that the acquired signal fluctuations have to be multiplied for n − 1 
time lags to obtain Gn. To generate SOFI images of higher orders, it is, however, 
necessary to transform the nth-order correlation functions into nth-order cumulant 
functions Cn(r,τ1,…τn−1). The reason is that all cross-terms caused by lower-order 
correlation contributions are eliminated in cumulants, so that the nth-order cumulant 
consists only of terms containing the nth power of the PSF. 
Beside cumulant analysis, SOFI can take advantage of cross-cumulant calculation 
by determining the cross correlation between pixels that surround the pixel of 
interest. The mathematical description of this approach (228) is beyond the scope of 
this short overview, but it is worth mentioning that the additional information of 
cross-cumulants can be used to reduce the noise in SOFI images even though no 
additional resolution is gained. This is especially useful when short acquisition 
times are used. 
B.2.2  TRPV1-EYQ1 for SOFI 
So far, most of the reported optical switches for SOFI applications are fusion 
constructs of the reversibly photoswitchable Dronpa protein (232). Dronpa is a 
green emitter with optical properties similar to the popular genetically encodable 
marker EGFP. Yet, SOFI is in principle applicable to any optical switcher. On 
account of the peculiar optical properties of EYQ1, namely its rather high 
photoswitching yields (similar to Dronpa), and its yellow emission that affords an 
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intermediate detection channel between those of green and red fluorescent proteins, 
we set out to test this mutant for SOFI application. More specifically, we engineered 
a TRPV1-EYQ1 fusion construct to image the morphological pattern of the receptor 
on the cell membrane at spatial scales below the diffraction limit (<250-300 nm).  
TRPV1-EYQ1 was obtained by site direct mutagenesis of TRPV1-EYFP 
construct. The photochromic capability of this construct were assessed in CHO K1 
cells by TIRF microscopy (233). Excitation was set to 488 nm, the emission was 
collected between 520 and 550 nm, and a dichroic filter at 502 nm separated out 




Figure B.6. On↔off photoswitching cycles of EYQ1 linked to TRPV1 receptor and 
expressed on the membrane of CHO cell. Microscopy images were taken in TIRF mode. 
Upper panel: TRPV1-EYQ1 on a cell membrane was concomitantly imaged and switched off 
by excitation at 488 nm; the first 5 panel show the progressive decay of TRPV1-EYQ1 
fluorescence with time; the last panel shows the effect of adding a brief 405 nm pulse: the 
original fluorescence was almost completely restored. Lower panel: mean fluorescence of the 
same cell undergoing 22 on↔off photoswitching cycles; below is reported, as a colored 
scheme, the illumination sequence of 488 and 405 nm lasers. 
 
Results showed that TRPV1-EYQ1 retains the same photoswiching behavior of 
EYQ1 alone (Fig. B.6), with a similar irreversible loss per switching cycle (3-4%). 
Fluorescence flickering of TRPV1-EYQ1 at membrane level was very evident when 
the acquisition time was shortened to 10-20 ms. 488 nm is a convenient wavelength 
to promote the reversible photoswitching of EYQ1, since at this wavelength the dark 
neutral state retains a non negligible absorption (Fig. B.2), eventually affording a 
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photostationary state between off and on states. Thus, we set out to collect time-
lapses to generate SOFI images. Experimentally, we acquired 1000-5000 sequential 
images (10 or 20 ms per frame) and the time-lapse was analyzed by using a second-
order cross-cumulant analysis followed by a Richardson-Lucy deconvolution, as 
implemented in the Localizer software (234). Fig B.7 displays the average intensity, 
as calculated on the time stack, relevant to the membrane of a single cell; this image 
corresponds to a conventional TIRF acquisition. Fig B.6B, instead, shows the image 
after SOFI processing. Although 2nd order SOFI increases the spatial resolution by 
only a √2 factor (squeezing the initial PSF from 270 nm to 190 nm), the SOFI image 
enhances greatly the understanding of the spatial morphology of receptor (Fig. B.7). 
In particular, TRPV1 forms a complex meshwork that extends all over the cell 
membrane and up to filipodia-like protrusions. The latter structures can be used to 
infer the spatial resolution enhancement, and the comparison of otherwise hidden 
substructures in the ≈200 nm scale (Fig B.7C). From the resolution viewpoint, these 
results are comparable to other examples reported in recent literature (230,235). 
 
 
Figure B.7. Superresolution imaging with SOFI. TIRF intensity image (A) and 
deconvolved SOFI image (B) acquired on CHO cells transfected with TRPV1-EYQ1 (Scale 
bars 5 µm). (C) Intensity vs, distance along the red (panel A) and blue (panel B) lines.  
In chapter 6 it was shown that the complexes of TRPV1 with microtubules 
(TRPV1-T) and caveolin-1 (TRPV1-C) do not overlap in space and reside in 
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membrane patches of significantly different sizes, 360±40 nm for TRPV1-C and 
860±300 nm for TRPV1-T respectively. Accordingly, we set out to investigate 
whether SOFI was able to identify small structures, presumably attributable to 
TRPV1-C, in the meshwork of TRPV1 membrane distribution. For this, we 
collected time lapses (40 ms, 1250 images) over small regions of the membrane (7.2 
x 7.2 mm), with the minimum pixel size allowed by our setup (110 nm); the time-
lapse was processed according to the SOFI-deconvolution algorithm (Fig. B.8). We 
were able to identify a few substructures with size ranging between 200 and 300 nm 
that could be assigned to interaction patches between TRPV1 and caveolin-1 (Fig. 
B.8). It is worth noting that SOFI greatly enhanced the understanding of the spatial 




Fig. B.7. SOFI imaging of a small cell region. (A) TIRF and  (B) second-order SOFI 
image of a selected region of cell (Scale bars, 1 µm.) (C) Plot profile along the yellow line in 
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